: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription

Articles published in J Neurooncol
Retrieve available abstracts of 918 articles:
HTML format

Single Articles

April 2024

CZARNOTA GJ
Comment in reply to Chen et al. Journal of Neuro-Oncology (2023) 165:535-545 "Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study".
J Neurooncol. 2024 Apr 19. doi: 10.1007/s11060-024-04675.
PubMed

CONRAD K, Lober-Handwerker R, Hazaymeh M, Rohde V, et al
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model.
J Neurooncol. 2024 Apr 19. doi: 10.1007/s11060-024-04683.
PubMed Abstract available

DESAI J, Rajkumar S, Shepard MJ, Herbst J, et al
National trends in the treatment of adult diffuse midline gliomas: a rare clinical scenario.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04663.
PubMed Abstract available

SALAME AAM, Charchar HLS, de Oliveira Dourado JP, Mendonca B, et al
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5- a case series.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04680.
PubMed Abstract available

MASHIACH E, Alzate JD, De Nigris Vasconcellos F, Adams S, et al
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04651.
PubMed Abstract available

GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04668.
PubMed Abstract available

KOCHER D, Cao L, Guiho R, Langhammer M, et al
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
J Neurooncol. 2024 Apr 17. doi: 10.1007/s11060-024-04672.
PubMed Abstract available

WILSON L, Atallah A, Romero JM
Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma.
J Neurooncol. 2024 Apr 15. doi: 10.1007/s11060-024-04666.
PubMed

SHEEHAN JP, Trifiletti DM, Lehrer EJ
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?
J Neurooncol. 2024 Apr 11. doi: 10.1007/s11060-024-04678.
PubMed

CHEN KT, Huang CY, Pai PC, Yang WC, et al
Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04671.
PubMed

KONDO N, Kinouchi T, Natsumeda M, Matsuzaki J, et al
Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy.
J Neurooncol. 2024 Apr 10. doi: 10.1007/s11060-024-04649.
PubMed Abstract available

MIRZAYEVA L, Ucar M, Kaymaz AM, Temel E, et al
Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience.
J Neurooncol. 2024 Apr 3. doi: 10.1007/s11060-024-04660.
PubMed Abstract available

MAHMOODIFAR S, Pangal DJ, Neman J, Zada G, et al
Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04630.
PubMed Abstract available

DMUKAUSKAS M, Cioffi G, Waite KA, Sloan AE, et al
Sex differences in adverse events in Medicare individuals >/= 66 years of age post glioblastoma treatment.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04652.
PubMed Abstract available

LU VM, Brun JD, Niazi TN, Brun JD, et al
Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04664.
PubMed Abstract available

XIANG Y, Chen Y, Xu Z, Zhou S, et al
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04662.
PubMed Abstract available

JOST J, Volker K, Brandt R, Stummer W, et al
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
J Neurooncol. 2024 Apr 1. doi: 10.1007/s11060-024-04629.
PubMed Abstract available

ROGERS JL, Wall T, Acquaye-Mallory AA, Boris L, et al
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
J Neurooncol. 2024;167:349-359.
PubMed Abstract available

March 2024

TONG E, Horsley P, Wheeler H, Wong M, et al
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
J Neurooncol. 2024 Mar 29. doi: 10.1007/s11060-024-04643.
PubMed Abstract available

FLORES-PACO P, Vargas-Aliaga A, Guevara MG, Lopera I, et al
A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.
J Neurooncol. 2024 Mar 27. doi: 10.1007/s11060-024-04618.
PubMed Abstract available

WATANABE G, Young K, Rauber E, Khan MF, et al
A systematic review of extraneural meningioma metastasis: timing, evolution and outlook.
J Neurooncol. 2024 Mar 26. doi: 10.1007/s11060-024-04659.
PubMed Abstract available

STRAUBE C, Combs SE, Bernhardt D, Gempt J, et al
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
J Neurooncol. 2024 Mar 23. doi: 10.1007/s11060-024-04633.
PubMed Abstract available

ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04635.
PubMed

ZAKI PG, Herr S, Shepard MJ
Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
J Neurooncol. 2024 Mar 22. doi: 10.1007/s11060-024-04602.
PubMed

FINK L, van Oorschot B, von Sass C, Dibue M, et al
Palliative care for in-patient malignant glioma patients in Germany.
J Neurooncol. 2024 Mar 20. doi: 10.1007/s11060-024-04611.
PubMed Abstract available

GEENS W, Vanlaer N, Nijland L, Van Laere S, et al
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
J Neurooncol. 2024 Mar 19. doi: 10.1007/s11060-024-04646.
PubMed Abstract available

BOBHOLZ SA, Hoefs A, Hamburger J, Lowman AK, et al
Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
J Neurooncol. 2024 Mar 18. doi: 10.1007/s11060-024-04641.
PubMed

ZHU P, Pichardo-Rojas PS, Dono A, Tandon N, et al
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
J Neurooncol. 2024 Mar 16. doi: 10.1007/s11060-024-04644.
PubMed Abstract available

CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
J Neurooncol. 2024 Mar 15. doi: 10.1007/s11060-024-04640.
PubMed

JIANG J, Li WB, Xiao SW
Correction to: Prognostic factors analysis of diffuse midline glioma.
J Neurooncol. 2024 Mar 15. doi: 10.1007/s11060-024-04634.
PubMed

PALAVANI LB, Silva GM, Borges PGLB, Ferreira MY, et al
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis.
J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04621.
PubMed Abstract available

DI NUNNO V, Lombardi G, Simonelli M, Minniti G, et al
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
J Neurooncol. 2024 Mar 8. doi: 10.1007/s11060-024-04589.
PubMed Abstract available

GRAILLON T, Salgues B, Horowitz T, Padovani L, et al
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.
J Neurooncol. 2024 Mar 7. doi: 10.1007/s11060-024-04622.
PubMed Abstract available

SINGH E, Gurses ME, Costello MC, Berke C, et al
Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04619.
PubMed

YOKOGAMI K, Watanabe T, Yamashita S, Mizuguchi A, et al
Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma.
J Neurooncol. 2024 Mar 6. doi: 10.1007/s11060-024-04625.
PubMed Abstract available

CHAKRAVARTI S, Kuo CC, Kazemi F, Kang A, et al
Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients.
J Neurooncol. 2024 Mar 4. doi: 10.1007/s11060-024-04627.
PubMed Abstract available

LIM MJR, Zhang Z, Zheng Y, Khoo IWL, et al
Effect of sarcopenia and frailty on outcomes among patients with brain metastases.
J Neurooncol. 2024 Mar 2. doi: 10.1007/s11060-023-04542.
PubMed Abstract available

CHEN Y, Ning J, Shu L, Wen L, et al
CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.
J Neurooncol. 2024 Mar 1. doi: 10.1007/s11060-023-04548.
PubMed Abstract available

KEGOYA Y, Otani Y, Inoue Y, Mizuta R, et al
Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review.
J Neurooncol. 2024 Mar 1. doi: 10.1007/s11060-024-04587.
PubMed Abstract available

SHEEHAN JP, Singh R, Trifiletti DM
Stereotactic radiosurgery for intracranial adenoid cystic carcinoma.
J Neurooncol. 2024;167:229-230.
PubMed

WILSON JS, Main C, Thorp N, Taylor RE, et al
The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review.
J Neurooncol. 2024;167:1-34.
PubMed Abstract available

RANADE M, Epari S, Shetty O, Dhanavade S, et al
CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.
J Neurooncol. 2024;167:189-198.
PubMed Abstract available

February 2024

YU M, Ge Y, Wang Z, Zhang Y, et al
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.
J Neurooncol. 2024 Feb 29. doi: 10.1007/s11060-024-04609.
PubMed Abstract available

CEPEDA S, Garcia-Garcia S, Arrese I, Sarabia R, et al
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery.
J Neurooncol. 2024 Feb 28. doi: 10.1007/s11060-024-04614.
PubMed Abstract available

JALLOH M, Kankam SB
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence.
J Neurooncol. 2024 Feb 23. doi: 10.1007/s11060-024-04606.
PubMed

YILMAZ MT, Kahvecioglu A, Yazici G, Mohammadipour S, et al
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.
J Neurooncol. 2024 Feb 22. doi: 10.1007/s11060-024-04607.
PubMed Abstract available

JIANG J, Li WB, Xiao SW
Prognostic factors analysis of diffuse midline glioma.
J Neurooncol. 2024 Feb 21. doi: 10.1007/s11060-024-04605.
PubMed Abstract available

EHRET F, Zuhlke O, Schweizer L, Kahn J, et al
Validation of a methylation-based signature for subventricular zone involvement in glioblastoma.
J Neurooncol. 2024 Feb 20. doi: 10.1007/s11060-024-04570.
PubMed Abstract available

DASGUPTA P, Ou A, Lin H, Gregory T, et al
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-023-04551.
PubMed Abstract available

BACCILI CURY MEGID T, Baskurt Z, Ma LX, Barron CC, et al
Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-024-04576.
PubMed Abstract available

BOBHOLZ SA, Hoefs A, Hamburger J, Lowman AK, et al
Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response.
J Neurooncol. 2024 Feb 19. doi: 10.1007/s11060-024-04593.
PubMed Abstract available

UMEKAWA M, Shinya Y, Hasegawa H, Morshed RA, et al
Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery.
J Neurooncol. 2024 Feb 18. doi: 10.1007/s11060-023-04537.
PubMed Abstract available

ARNOLD LM, Hoshina Y, Lee H, Colman H, et al
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04588.
PubMed Abstract available

SHEEHAN JP, Mantziaris G, Bunevicius A
Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04592.
PubMed

SHIRAI Y, Ueno T, Kojima S, Ikeuchi H, et al
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
J Neurooncol. 2024 Feb 16. doi: 10.1007/s11060-024-04563.
PubMed Abstract available

WASILEWSKI D, Onken J, Horicke P, Bukatz J, et al
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection.
J Neurooncol. 2024 Feb 15. doi: 10.1007/s11060-024-04590.
PubMed Abstract available

DONO A, Torres J, Nunez L, Arevalo O, et al
Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04575.
PubMed Abstract available

KOAY JM, Michaelides L, Moniz-Garcia DP, Quinones-Hinojosa A, et al
Repeated surgical resections for management of high-grade glioma and its impact on quality of life.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04600.
PubMed Abstract available

ANGELOVA P, Gicheva M
Comment: Additional factors affecting cognitive function in low grade glioma patients.
J Neurooncol. 2024 Feb 13. doi: 10.1007/s11060-024-04598.
PubMed

WATANABE G, Wong JM, Estes B, Khan MF, et al
Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
J Neurooncol. 2024 Feb 12. doi: 10.1007/s11060-024-04584.
PubMed Abstract available

FAIRCHILD A, Salama JK, Godfrey D, Wiggins WF, et al
Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04594.
PubMed Abstract available

MIRIAN C, Jensen LR, Juratli TA, Maier AD, et al
The importance of considering competing risks in recurrence analysis of intracranial meningioma.
J Neurooncol. 2024 Feb 10. doi: 10.1007/s11060-024-04572.
PubMed Abstract available

ALHALABI OT, Dao Trong P, Kaes M, Jakobs M, et al
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis.
J Neurooncol. 2024 Feb 9. doi: 10.1007/s11060-024-04595.
PubMed Abstract available

KERIC N, Krenzlin H, Kalasauskas D, Freyschlag CF, et al
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04585.
PubMed Abstract available

AVERBUCH I, Tschernichovsky R, Yust-Katz S, Rotem O, et al
Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.
J Neurooncol. 2024 Feb 7. doi: 10.1007/s11060-024-04562.
PubMed Abstract available

TRAN S, Lapidus A, Neal A, Peters KB, et al
A systematic review of the impact of brain tumours on risk of motor vehicle crashes.
J Neurooncol. 2024 Feb 6. doi: 10.1007/s11060-024-04586.
PubMed Abstract available

SALANS M, Ni L, Morin O, Ziemer B, et al
Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty.
J Neurooncol. 2024 Feb 5. doi: 10.1007/s11060-024-04578.
PubMed Abstract available

TANG JD, Mills MN, Nakashima J, Dohm AE, et al
Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
J Neurooncol. 2024 Feb 3. doi: 10.1007/s11060-023-04543.
PubMed Abstract available

ZIMMERMANN MLM, Breedt LC, Centeno EGZ, Reijneveld JC, et al
The relationship between pathological brain activity and functional network connectivity in glioma patients.
J Neurooncol. 2024 Feb 3. doi: 10.1007/s11060-024-04577.
PubMed Abstract available

HAMMER Y, Najjar W, Kahanov L, Joskowicz L, et al
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline.
J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04580.
PubMed Abstract available

WANG B, Liu Y, Zhang J, Yin S, et al
Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study.
J Neurooncol. 2024 Feb 1. doi: 10.1007/s11060-024-04583.
PubMed Abstract available

KHOWAL S, Zhang D, Yong WH, Heaney AP, et al
Whole-exome sequencing reveals genetic variants that may play a role in neurocytomas.
J Neurooncol. 2024;166:471-483.
PubMed Abstract available

January 2024

SINGH E, Gurses ME, Costello MC, Lu VM, et al
Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-024-04582.
PubMed Abstract available

TANAKA T, Tamura R, Takei J, Morimoto Y, et al
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
J Neurooncol. 2024 Jan 31. doi: 10.1007/s11060-023-04544.
PubMed Abstract available

GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol. 2024 Jan 30. doi: 10.1007/s11060-024-04581.
PubMed

DASGUPTA P, Rousseau JF
Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04574.
PubMed Abstract available

PETRONEK MS, Bodeker KL, Lee CY, Teferi N, et al
Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.
J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04571.
PubMed Abstract available

VAN OPIJNEN MP, Broekman MLD, Cuppen E, Dubbink HJ, et al
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
J Neurooncol. 2024 Jan 29. doi: 10.1007/s11060-024-04568.
PubMed Abstract available

YEKULA A, Gessler DJ, Ferreira C, Shah R, et al
GammaTile((R)) (GT) as a brachytherapy platform for rapidly proliferating glioblastomas: from case series to clinical trials.
J Neurooncol. 2024 Jan 28. doi: 10.1007/s11060-023-04545.
PubMed Abstract available

GONZALEZ-APONTE MF, Damato AR, Trebucq LL, Simon T, et al
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
J Neurooncol. 2024 Jan 26. doi: 10.1007/s11060-023-04535.
PubMed Abstract available

KREATSOULAS D, Damante M, Cua S, Lonser RR, et al
Adjuvant convection-enhanced delivery for the treatment of brain tumors.
J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04552.
PubMed Abstract available

MULLER SJ, Khadhraoui E, Ganslandt O, Henkes H, et al
MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-024-04573.
PubMed Abstract available

GARCIA MA, Turner A, Brachman DG
The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
J Neurooncol. 2024 Jan 23. doi: 10.1007/s11060-023-04523.
PubMed Abstract available

REESE JC, Fadel HA, Pawloski JA, Samir M, et al
Laser interstitial thermal therapy for deep-seated perivascular brain tumors is not associated with distal ischemia.
J Neurooncol. 2024 Jan 19. doi: 10.1007/s11060-023-04546.
PubMed Abstract available

RYNDA AY, Rostovthev DM, Zabrodskaya YM, Olyushin VE, et al
Immunotherapy with autologous dendritic cells in the complex treatment of malignant gliomas - results.
J Neurooncol. 2024 Jan 16. doi: 10.1007/s11060-023-04559.
PubMed Abstract available

ON J, Natsumeda M, Takahashi H, Koyama A, et al
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
J Neurooncol. 2024 Jan 16. doi: 10.1007/s11060-023-04555.
PubMed Abstract available

ZAPANTA RINONOS S, Li T, Pianka ST, Prins TJ, et al
dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma.
J Neurooncol. 2024 Jan 15. doi: 10.1007/s11060-023-04531.
PubMed Abstract available

KUAH XYC, Lucas-Herald AK, McCarrison S, Boyle R, et al
Presentation and outcomes of paediatric craniopharyngioma in the west of Scotland: a 25 year experience.
J Neurooncol. 2024 Jan 15. doi: 10.1007/s11060-023-04490.
PubMed Abstract available

DOGAN E, Yildirim Z, Akalin T, Ozgiray E, et al
Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours.
J Neurooncol. 2024 Jan 12. doi: 10.1007/s11060-023-04556.
PubMed Abstract available

DAGHER R, Gad M, da Silva de Santana P, Sadeghi MA, et al
Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
J Neurooncol. 2024 Jan 11. doi: 10.1007/s11060-023-04528.
PubMed Abstract available

MIYAKOSHI A, Ubukata N, Miyake H, Shoji-Asahina A, et al
Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study.
J Neurooncol. 2024 Jan 11. doi: 10.1007/s11060-024-04566.
PubMed Abstract available

BERGER A, Mullen R, Bernstein K, Mashiach E, et al
Volumetric growth rate of incidentally found meningiomas on immunotherapy.
J Neurooncol. 2024 Jan 9. doi: 10.1007/s11060-023-04558.
PubMed Abstract available

HUDSON K, Mondia MW, Zhang Y, Saha S, et al
The role of microRNAs in brain metastasis.
J Neurooncol. 2024 Jan 9. doi: 10.1007/s11060-023-04541.
PubMed Abstract available

ZHANG Q, Dai Z, Chen Y, Li Q, et al
Endosome associated trafficking regulator 1 promotes tumor growth and invasion of glioblastoma multiforme via inhibiting TNF signaling pathway.
J Neurooncol. 2024 Jan 8. doi: 10.1007/s11060-023-04527.
PubMed Abstract available

ZEUNER S, Vollmer J, Sigaud R, Oppermann S, et al
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol. 2024 Jan 7. doi: 10.1007/s11060-023-04526.
PubMed Abstract available

YADAV N, Purow BW
Understanding current experimental models of glioblastoma-brain microenvironment interactions.
J Neurooncol. 2024 Jan 5. doi: 10.1007/s11060-023-04536.
PubMed Abstract available

ZHANG JF, Okai B, Iovoli A, Goulenko V, et al
Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.
J Neurooncol. 2024 Jan 4. doi: 10.1007/s11060-023-04524.
PubMed Abstract available

KAMBE A, Kitao S, Ochiai R, Hosoya T, et al
The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
J Neurooncol. 2024 Jan 2. doi: 10.1007/s11060-023-04550.
PubMed Abstract available

HESHAM D, On J, Alshahaby N, Amer N, et al
Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
J Neurooncol. 2024;166:27-38.
PubMed Abstract available

FADUL CE, Thakur A, Kim J, Kassay-McAllister J, et al
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.
J Neurooncol. 2024;166:321-330.
PubMed Abstract available

OBRECHT-STURM D, Pfaff E, Mynarek M, Bison B, et al
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
J Neurooncol. 2024;166:359-368.
PubMed Abstract available

EBADI M, Morse M, Gooley T, Ermoian R, et al
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
J Neurooncol. 2024;166:351-357.
PubMed Abstract available

SHEEHAN JP, Michalopoulos GD, Katsos K, Bydon M, et al
The NeuroPoint alliance SRS & tumor QOD registries.
J Neurooncol. 2024;166:257-264.
PubMed Abstract available

FENG J, Zhang J, Chen L, Li C, et al
Treatment outcomes and risk factors of patients with intracranial germ cell tumour with choriocarcinoma element or beta-HCG level higher than 500 IU/L.
J Neurooncol. 2024;166:331-339.
PubMed Abstract available

HONG S, Garces YI, Price KA, Shinya Y, et al
Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients.
J Neurooncol. 2024;166:369-376.
PubMed Abstract available

December 2023

NORIKANE T, Mitamura K, Yamamoto Y, Manabe Y, et al
Comparative evaluation of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma.
J Neurooncol. 2023 Dec 31. doi: 10.1007/s11060-023-04534.
PubMed Abstract available

GATELY L, Mesia C, Sepulveda JM, Del Barco S, et al
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
J Neurooncol. 2023 Dec 28. doi: 10.1007/s11060-023-04513.
PubMed Abstract available

ARORA H, Mammi M, Patel NM, Zyfi D, et al
Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis.
J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04549.
PubMed Abstract available

YANG ZC, Yin CD, Yeh FC, Xue BW, et al
Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04539.
PubMed Abstract available

BENNEBROEK CA, Schouten CR, Montauban-van Swijndregt MC, Saeed P, et al
Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.
J Neurooncol. 2023 Dec 27. doi: 10.1007/s11060-023-04516.
PubMed Abstract available

REN L, Chen J, Deng J, Qing X, et al
The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.
J Neurooncol. 2023 Dec 26. doi: 10.1007/s11060-023-04511.
PubMed Abstract available

CHOU CJ, Yang HC, Chang PY, Chen CJ, et al
Automated identification and quantification of metastatic brain tumors and perilesional edema based on a deep learning neural network.
J Neurooncol. 2023 Dec 22. doi: 10.1007/s11060-023-04540.
PubMed Abstract available

MIJAJLOVIC V, Miler M, Ilic R, Rasic D, et al
Oncogene-induced senescence in meningiomas-an immunohistochemical study.
J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04532.
PubMed Abstract available

KINSLOW CJ, Siegelin MD, Iwamoto FM, Gallitto M, et al
MGMT promoter methylation in 1p19q-intact gliomas.
J Neurooncol. 2023 Dec 20. doi: 10.1007/s11060-023-04515.
PubMed Abstract available

LU VM, Khalafallah AM, Jaman E, Gurses ME, et al
Clinical course of ventriculoperitoneal shunting for hydrocephalus following glioblastoma surgery: a systematic review and meta-analysis.
J Neurooncol. 2023 Dec 19. doi: 10.1007/s11060-023-04538.
PubMed Abstract available

ABETE-FORNARA G, Bintintan Socaciu P, Fanizzi C, Fiore G, et al
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study.
J Neurooncol. 2023 Dec 18. doi: 10.1007/s11060-023-04533.
PubMed Abstract available

CHEN Q, Wang K, Ren X, Zhao X, et al
Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [(11)C]methionine PET.
J Neurooncol. 2023 Dec 14. doi: 10.1007/s11060-023-04529.
PubMed Abstract available

CHANG CT, Chen HH, Chuang CC, Chang SH, et al
Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis.
J Neurooncol. 2023 Dec 8. doi: 10.1007/s11060-023-04503.
PubMed Abstract available

CHEN KT, Huang CY, Pai PC, Yang WC, et al
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
J Neurooncol. 2023 Dec 7. doi: 10.1007/s11060-023-04517.
PubMed Abstract available

MIAO Q, Zheng X, Li L, Zheng X, et al
Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.
J Neurooncol. 2023;165:517-525.
PubMed Abstract available

WILLEMS YCP, Vaassen F, Zegers CML, Postma AA, et al
Anatomical changes in resection cavity during brain radiotherapy.
J Neurooncol. 2023;165:479-486.
PubMed Abstract available

RAMMELOO E, Schouten JW, Krikour K, Bos EM, et al
Preoperative assessment of eloquence in neurosurgery: a systematic review.
J Neurooncol. 2023;165:413-430.
PubMed Abstract available

SHEN CI, Chiang CL, Huang HC, Tseng YH, et al
Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study.
J Neurooncol. 2023;165:459-465.
PubMed Abstract available

WIJAYA JH, Patel UD, Quintero-Consuegra MD, Aguilera-Pena MP, et al
Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis.
J Neurooncol. 2023;165:431-438.
PubMed Abstract available

LYNES J, Khan I, Aguilera C, Rubino S, et al
Development of a "Geo-Tagged" tumor sample registry: intra-operative linkage of sample location to imaging.
J Neurooncol. 2023;165:449-458.
PubMed Abstract available

SELT F, El Damaty A, Schuhmann MU, Sigaud R, et al
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
J Neurooncol. 2023;165:467-478.
PubMed Abstract available

November 2023

SHEEHAN J, Mantziaris G, Dumont C, Pikis S, et al
Incidental meningiomas: a current and increasingly common challenge.
J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04525.
PubMed

BAUMGARTEN P, Prange G, Kamp MA, Monden D, et al
Treatment of very elderly glioblastoma patients >/= 75 years of age: whom to treat.
J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04518.
PubMed Abstract available

ANDREWS CE, Zilberberg J, Perez-Olle R, Exley MA, et al
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy.
J Neurooncol. 2023 Nov 29. doi: 10.1007/s11060-023-04491.
PubMed Abstract available

KLEINBERG L, Ye X, Supko J, Stevens GHJ, et al
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).
J Neurooncol. 2023 Nov 28. doi: 10.1007/s11060-023-04514.
PubMed Abstract available

YAVUZ BB, Kilinc F, Kanyilmaz G, Aktan M, et al
Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients.
J Neurooncol. 2023 Nov 27. doi: 10.1007/s11060-023-04521.
PubMed Abstract available

CHIANG CL, Yang HC, Liao YT, Luo YH, et al
Treatment and survival of patients with small cell lung cancer and brain metastasis.
J Neurooncol. 2023 Nov 20. doi: 10.1007/s11060-023-04512.
PubMed Abstract available

QIU X, Gao J, Hu J, Yang J, et al
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center.
J Neurooncol. 2023 Nov 17. doi: 10.1007/s11060-023-04401.
PubMed Abstract available

QIN N, Paisana E, Picard D, Leprivier G, et al
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
J Neurooncol. 2023 Nov 17. doi: 10.1007/s11060-023-04508.
PubMed Abstract available

VOGLIS S, Padevit L, van Niftrik CHB, Kalin V, et al
Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases.
J Neurooncol. 2023 Nov 10. doi: 10.1007/s11060-023-04478.
PubMed Abstract available

KHAN AB, Dang HQ, Gopakumar S, Lazaro T, et al
Clinical outcomes of stereotactic biopsy on children with pontine diffuse midline glioma.
J Neurooncol. 2023 Nov 9. doi: 10.1007/s11060-023-04475.
PubMed Abstract available

KIM N, Lee J, Nam DH, Lee JI, et al
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol. 2023 Nov 8. doi: 10.1007/s11060-023-04498.
PubMed

NASLUND O, Strand PS, Solheim O, Al Masri M, et al
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?
J Neurooncol. 2023 Nov 8. doi: 10.1007/s11060-023-04482.
PubMed Abstract available

YAMAMOTO S, Okita Y, Arita H, Sanada T, et al
Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesions.
J Neurooncol. 2023 Nov 2. doi: 10.1007/s11060-023-04454.
PubMed Abstract available

LIN HT, Lin CM, Wu YY, Chang WH, et al
Predictors for delayed awakening in adult glioma patients receiving awake craniotomy under monitored anesthesia care.
J Neurooncol. 2023 Nov 2. doi: 10.1007/s11060-023-04494.
PubMed Abstract available

CHEN YH, Moore D, Lee CC, Su YH, et al
Focused ultrasound for brain metastases: an update on global clinical trials.
J Neurooncol. 2023 Nov 1. doi: 10.1007/s11060-023-04492.
PubMed Abstract available

HONG Y, Miao Q, Zheng X, Xu Y, et al
Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis.
J Neurooncol. 2023;165:301-312.
PubMed Abstract available

PRICE M, Neff C, Kruchko C, Barnholtz-Sloan JS, et al
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
J Neurooncol. 2023;165:279-290.
PubMed Abstract available

KO MK, Kwak YK, Choi BO, Jeun SS, et al
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?
J Neurooncol. 2023;165:321-328.
PubMed Abstract available

ZAMARUD A, Marianayagam NJ, Park DJ, Yener U, et al
The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
J Neurooncol. 2023;165:373-379.
PubMed Abstract available

October 2023

KRASSNIG S, Leber SL, Orthmann A, Golob-Schwarzl N, et al
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol. 2023 Oct 31. doi: 10.1007/s11060-023-04451.
PubMed Abstract available

LEHRER EJ, Khosla AA, Ozair A, Gurewitz J, et al
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04413.
PubMed Abstract available

MOHAMMAD AH, Jatana S, Ruiz-Barerra MA, Khalaf R, et al
Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04485.
PubMed Abstract available

MA S, Lee H, Jo WY, Byun YH, et al
The Warburg effect in patients with brain tumors: a comprehensive analysis of clinical significance.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04486.
PubMed Abstract available

CROMPTON D, Koffler D, Fekrmandi F, Lehrer EJ, et al
Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04466.
PubMed Abstract available

GROB ST, Miller KR, Sanford B, Donson AM, et al
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors.
J Neurooncol. 2023 Oct 25. doi: 10.1007/s11060-023-04472.
PubMed Abstract available

ELLIS EM, Drumm MR, Rai SM, Huang J, et al
Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures.
J Neurooncol. 2023 Oct 24. doi: 10.1007/s11060-023-04481.
PubMed Abstract available

STROWD R, Ellingson B, Raymond C, Yao J, et al
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
J Neurooncol. 2023 Oct 21. doi: 10.1007/s11060-023-04456.
PubMed Abstract available

KIM N, Lee J, Nam DH, Lee JI, et al
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol. 2023 Oct 20. doi: 10.1007/s11060-023-04465.
PubMed Abstract available

YU Y, Chen H, Tian Z, Zhang Q, et al
Improved survival outcome with not-delayed radiotherapy and immediate PD-1/PD-L1 inhibitor for non-small-cell lung cancer patients with brain metastases.
J Neurooncol. 2023 Oct 17. doi: 10.1007/s11060-023-04459.
PubMed Abstract available

NAKAJIMA R, Kinoshita M, Okita H, Nakada M, et al
Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level.
J Neurooncol. 2023 Oct 17. doi: 10.1007/s11060-023-04479.
PubMed Abstract available

HOU C, Shi S, Gao M, Ji J, et al
Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy.
J Neurooncol. 2023 Oct 11. doi: 10.1007/s11060-023-04449.
PubMed Abstract available

DEJONCKHEERE CS, Layer JP, Hamed M, Layer K, et al
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04464.
PubMed Abstract available

BORST GR, Post R
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis.
J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04457.
PubMed

PANDYA SHESH B, Walter V, Palsa K, Slagle-Webb B, et al
Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma.
J Neurooncol. 2023 Oct 9. doi: 10.1007/s11060-023-04415.
PubMed Abstract available

ERNSTER AE, Body A, Deleyrolle P, St Clair J, et al
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors.
J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04469.
PubMed Abstract available

KOTCH C, Si SJ, Desai K, Caminada P, et al
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
J Neurooncol. 2023 Oct 7. doi: 10.1007/s11060-023-04468.
PubMed Abstract available

DADEY DYA, Medress ZA, Sharma M, Ugiliweneza B, et al
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
J Neurooncol. 2023 Oct 4. doi: 10.1007/s11060-023-04460.
PubMed Abstract available

COVELL MM, Warrier A, Rumalla KC, Dehney CM, et al
RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04461.
PubMed Abstract available

WELLER J, Zeyen T, Schafer N, Schaub C, et al
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04470.
PubMed Abstract available

VOLLMER J, Ecker J, Hielscher T, Valinciute G, et al
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
J Neurooncol. 2023 Oct 3. doi: 10.1007/s11060-023-04445.
PubMed Abstract available

QUE T, Huang G, Tan JE, Zhang P, et al
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma.
J Neurooncol. 2023 Oct 2. doi: 10.1007/s11060-023-04399.
PubMed Abstract available

STOCKDILL ML, Mendoza T, Armstrong TS, Miaskowski C, et al
Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors.
J Neurooncol. 2023;165:181-190.
PubMed Abstract available

BAI K, Chen X, Qi X, Zhang Y, et al
Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
J Neurooncol. 2023;165:149-160.
PubMed Abstract available

ONISHI S, Yamasaki F, Amatya VJ, Takayasu T, et al
Residual diffusion-weighted imaging hyperintense signal in primary central nervous system lymphoma can predict early recurrence.
J Neurooncol. 2023;165:171-179.
PubMed Abstract available

GUTIERREZ-VALENCIA E, Sanchez I, Valles A, Diaz O, et al
Pachymeningeal disease: a systematic review and metanalysis.
J Neurooncol. 2023;165:29-39.
PubMed Abstract available

September 2023

VAN T HEK R, Ortiz-Herrera JL, Salazar-Pigeon A, Ramirez-Loera C, et al
Age and sex disparities in Latin-American adults with gliomas: a systematic review and meta-analysis.
J Neurooncol. 2023 Sep 29. doi: 10.1007/s11060-023-04448.
PubMed Abstract available

KARABACAK M, Jagtiani P, Carrasquilla A, Shrivastava RK, et al
Advancing personalized prognosis in atypical and anaplastic meningiomas through interpretable machine learning models.
J Neurooncol. 2023 Sep 28. doi: 10.1007/s11060-023-04463.
PubMed Abstract available

VAN DER MEER PB, Dirven L, Fiocco M, Vos MJ, et al
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study.
J Neurooncol. 2023 Sep 27. doi: 10.1007/s11060-023-04450.
PubMed Abstract available

LI L, Shao MY, Zou SC, Xiao ZF, et al
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
J Neurooncol. 2023 Sep 22. doi: 10.1007/s11060-023-04429.
PubMed

MARWAH R, Xing D, Squire T, Soon YY, et al
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity.
J Neurooncol. 2023 Sep 21. doi: 10.1007/s11060-023-04441.
PubMed Abstract available

SHEEHAN JP, Trifiletti DM
Comments: neurosurgery and radiation oncology advances have improved visual outcomes for skull base meningioma patients.
J Neurooncol. 2023 Sep 18. doi: 10.1007/s11060-023-04400.
PubMed

KUAN AS, Chiang CL, Wu HM, Yang HC, et al
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
J Neurooncol. 2023 Sep 18. doi: 10.1007/s11060-023-04452.
PubMed Abstract available

FURUTA T, Negoto T, Miyoshi H, Moritsubo M, et al
Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04447.
PubMed Abstract available

IGLSEDER S, Iglseder A, Beliveau V, Heugenhauser J, et al
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04414.
PubMed Abstract available

KATLOWITZ KA, Athukuri P, Sharma H, Dang H, et al
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04446.
PubMed Abstract available

JABEHDAR MARALANI P, Stewart J, Hiremath S, Lawrence L, et al
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma.
J Neurooncol. 2023 Sep 14. doi: 10.1007/s11060-023-04440.
PubMed Abstract available

DIMOV D, Brainman D, Berger B, Coras R, et al
The role of cytoreductive surgery in multifocal/multicentric glioblastomas.
J Neurooncol. 2023 Sep 12. doi: 10.1007/s11060-023-04410.
PubMed Abstract available

NINATTI G, Pini C, Bono BC, Gelardi F, et al
The prognostic power of [(11)C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.
J Neurooncol. 2023 Sep 11. doi: 10.1007/s11060-023-04438.
PubMed Abstract available

ALZATE JD, Mullen R, Mashiach E, Bernstein K, et al
EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease.
J Neurooncol. 2023 Sep 10. doi: 10.1007/s11060-023-04442.
PubMed Abstract available

SOHN B, Park K, Ahn SS, Park YW, et al
Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
J Neurooncol. 2023 Sep 10. doi: 10.1007/s11060-023-04435.
PubMed Abstract available

HOU Z, Hu J, Liu X, Yan Z, et al
Decision system for extent of resection in WHO grade 3 gliomas: a Chinese Glioma Genome Atlas database analysis.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04420.
PubMed Abstract available

WU YY, Chen KT, Chu YC, Yeh CC, et al
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04431.
PubMed Abstract available

MURTHA AN, Zaki PG, Shepard MJ
Letter to the editor: outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04434.
PubMed

LUCKETT PH, Olufawo M, Lamichhane B, Park KY, et al
Predicting survival in glioblastoma with multimodal neuroimaging and machine learning.
J Neurooncol. 2023 Sep 5. doi: 10.1007/s11060-023-04439.
PubMed Abstract available

HUNG JS, Su YH, Chen CJ, Chiang CL, et al
Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment.
J Neurooncol. 2023 Sep 1. doi: 10.1007/s11060-023-04425.
PubMed Abstract available

CIFARELLI CP, Vargo JA, Sener U, Cifarelli DT, et al
Intracranial intraoperative radiotherapy (IORT): evaluation of electrocorticography and peri-operative seizure risk.
J Neurooncol. 2023;164:423-430.
PubMed Abstract available

MINNITI G, Paolini S, Antonelli M, Gianno F, et al
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma.
J Neurooncol. 2023;164:331-339.
PubMed Abstract available

HOU L, Chen X, Qiu G, Qi X, et al
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis.
J Neurooncol. 2023;164:367-376.
PubMed Abstract available

FIGUEREDO LF, Shelton WJ, Tagle-Vega U, Sanchez E, et al
The state of art of awake craniotomy in Latin American countries: a scoping review.
J Neurooncol. 2023;164:287-298.
PubMed Abstract available

ID SAID B, Soliman H, Moravan V, Myrehaug S, et al
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer.
J Neurooncol. 2023;164:437-445.
PubMed Abstract available

ZENG C, Yang Q, Li Z, Wei Z, et al
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study.
J Neurooncol. 2023;164:643-653.
PubMed Abstract available

ZEYEN T, Paech D, Weller J, Schafer N, et al
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol. 2023;164:607-616.
PubMed Abstract available

August 2023

PERTZ M, Schlomer S, Seidel C, Hentschel B, et al
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up.
J Neurooncol. 2023 Aug 30. doi: 10.1007/s11060-023-04419.
PubMed Abstract available

JIA W, Zhai X, Jing X, Bao Q, et al
Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.
J Neurooncol. 2023 Aug 30. doi: 10.1007/s11060-023-04426.
PubMed Abstract available

WAGENER K, Beckhaus J, Boekhoff S, Friedrich C, et al
Publisher Correction to: Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
J Neurooncol. 2023 Aug 29. doi: 10.1007/s11060-023-04424.
PubMed

QURESHI HM, Tabor JK, Pickens K, Lei H, et al
Frailty and postoperative outcomes in brain tumor patients: a systematic review subdivided by tumor etiology.
J Neurooncol. 2023 Aug 25. doi: 10.1007/s11060-023-04416.
PubMed Abstract available

DE PIETRO R, Zaccaro L, Marampon F, Tini P, et al
The evolving role of reirradiation in the management of recurrent brain tumors.
J Neurooncol. 2023 Aug 25. doi: 10.1007/s11060-023-04407.
PubMed Abstract available

LEHRER EJ, Trifiletti DM, Sheehan JP
Stereotactic radiosurgery in patients with extensive brain metastases - supporting evidence and knowledge gaps.
J Neurooncol. 2023 Aug 21. doi: 10.1007/s11060-023-04422.
PubMed

EBIKO Y, Tamura K, Hara S, Inaji M, et al
T2-FLAIR mismatch sign correlates with (11)C-methionine uptake in lower-grade diffuse gliomas.
J Neurooncol. 2023 Aug 17. doi: 10.1007/s11060-023-04417.
PubMed Abstract available

GURRIERI L, Mercatali L, Ibrahim T, Fausti V, et al
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
J Neurooncol. 2023 Aug 16. doi: 10.1007/s11060-023-04357.
PubMed Abstract available

LAWSON MCLEAN A
Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib.
J Neurooncol. 2023 Aug 10. doi: 10.1007/s11060-023-04408.
PubMed

MIER-GARCIA JF, Ospina-Santa S, Orozco-Mera J, Ma R, et al
Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis.
J Neurooncol. 2023 Aug 10. doi: 10.1007/s11060-023-04409.
PubMed Abstract available

JABLONSKA PA, Muniz T, Ribeiro M, Liu ZA, et al
Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
J Neurooncol. 2023 Aug 8. doi: 10.1007/s11060-023-04404.
PubMed Abstract available

OTANI R, Ikegami M, Yamada R, Yajima H, et al
PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.
J Neurooncol. 2023 Aug 8. doi: 10.1007/s11060-023-04411.
PubMed Abstract available

HOLDAWAY M, Ablyazova F, Huda S, D'Amico RS, et al
First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial.
J Neurooncol. 2023 Aug 7. doi: 10.1007/s11060-023-04412.
PubMed Abstract available

LANG A, Jeron RL, Lontzek B, Kiesel B, et al
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis.
J Neurooncol. 2023 Aug 6. doi: 10.1007/s11060-023-04406.
PubMed Abstract available

NEUMANN B, Onken J, Konig N, Stetefeld H, et al
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
J Neurooncol. 2023 Aug 2. doi: 10.1007/s11060-023-04403.
PubMed Abstract available

AKINDURO OO, Ghaith AK, El-Hajj VG, Ghanem M, et al
Effect of race, sex, and socioeconomic factors on overall survival following the resection of intramedullary spinal cord tumors.
J Neurooncol. 2023;164:75-85.
PubMed Abstract available

NETH BJ, Webb MJ, White J, Uhm JH, et al
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
J Neurooncol. 2023;164:239-247.
PubMed Abstract available

July 2023

NODA R, Kawashima M, Segawa M, Tsunoda S, et al
Fractionated versus staged gamma knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis.
J Neurooncol. 2023 Jul 31. doi: 10.1007/s11060-023-04374.
PubMed Abstract available

HU T, Xuan R, Han E, Cai L, et al
SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling.
J Neurooncol. 2023 Jul 31. doi: 10.1007/s11060-023-04394.
PubMed Abstract available

MANTICA M, Drappatz J, Lieberman F, Hadjipanayis CG, et al
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
J Neurooncol. 2023 Jul 29. doi: 10.1007/s11060-023-04398.
PubMed Abstract available

VIOZZI I, Overduin CG, Rijpma A, Rovers MM, et al
MR-guided LITT therapy in patients with primary irresectable glioblastoma: a prospective, controlled pilot study.
J Neurooncol. 2023 Jul 28. doi: 10.1007/s11060-023-04371.
PubMed Abstract available

BALLO MT, Conlon P, Lavy-Shahaf G, Kinzel A, et al
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
J Neurooncol. 2023 Jul 26. doi: 10.1007/s11060-023-04348.
PubMed Abstract available

RAVIN R, Suarez-Meade P, Busse B, Blank PS, et al
Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.
J Neurooncol. 2023 Jul 25. doi: 10.1007/s11060-023-04349.
PubMed Abstract available

KHATRI VM, Mills MN, Oliver DE, Yu HM, et al
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases.
J Neurooncol. 2023 Jul 25. doi: 10.1007/s11060-023-04402.
PubMed Abstract available

SPILLE DC, Thomas C, Wagner A, Grauer OM, et al
Molecular predictors for decitabine efficacy in meningiomas - a pilot study.
J Neurooncol. 2023 Jul 21. doi: 10.1007/s11060-023-04379.
PubMed Abstract available

LAYER JP, Hamed M, Potthoff AL, Dejonckheere CS, et al
Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
J Neurooncol. 2023 Jul 21. doi: 10.1007/s11060-023-04380.
PubMed Abstract available

BUYUKTEPE M, Kaplan I, Bayatli E, Dogan H, et al
Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay.
J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04397.
PubMed Abstract available

ZHANG YT, Wang Y, Zhong XD, Chang J, et al
Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center.
J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04388.
PubMed Abstract available

TAORI S, Wei Z, Deng H, Hadjipanayis CG, et al
Stereotactic radiosurgery for patients with brain metastases from gastroesophageal cancers.
J Neurooncol. 2023 Jul 20. doi: 10.1007/s11060-023-04392.
PubMed Abstract available

YANG X, Ji C, Qi Y, Huang J, et al
Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.
J Neurooncol. 2023 Jul 18. doi: 10.1007/s11060-023-04390.
PubMed Abstract available

CHOJAK R, Fares J, Petrosyan E, Lesniak MS, et al
Cellular senescence in glioma.
J Neurooncol. 2023 Jul 17. doi: 10.1007/s11060-023-04387.
PubMed Abstract available

MALLICK S, Gupta S, Amariyil A, Kunhiparambath H, et al
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial.
J Neurooncol. 2023 Jul 15. doi: 10.1007/s11060-023-04391.
PubMed Abstract available

ONYIAH C, Shepard MJ
Letter: are there incidences of clinically relevant psychiatric symptoms during glioblastoma treatment?
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04376.
PubMed

MATSUI JK, Allen PK, Perlow HK, Johnson JM, et al
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04386.
PubMed Abstract available

OTANI R, Sadato D, Yamada R, Yajima H, et al
CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04381.
PubMed Abstract available

LEI H, Tabor JK, O'Brien J, Qin R, et al
Associations of race and socioeconomic status with outcomes after intracranial meningioma resection: a systematic review and meta-analysis.
J Neurooncol. 2023 Jul 13. doi: 10.1007/s11060-023-04393.
PubMed Abstract available

INDHARTY RS, Japardi I, Irina RS, Tandean S, et al
Comparison of direct cortical stimulation and transcranial magnetic stimulation in brain tumor surgery: systematic review and meta analyses.
J Neurooncol. 2023 Jul 12. doi: 10.1007/s11060-023-04378.
PubMed Abstract available

YADAV N, Babu D, Madigubba S, Panigrahi M, et al
Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
J Neurooncol. 2023 Jul 6. doi: 10.1007/s11060-023-04383.
PubMed Abstract available

MISHRA A, Koffler D, Calugaru E, Rowe N, et al
Let's make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases.
J Neurooncol. 2023 Jul 6. doi: 10.1007/s11060-023-04365.
PubMed Abstract available

TANRIKULU B, Yasar AH, Canpolat C, Corapcioglu F, et al
Preliminary findings of German-sourced ONC201 treatment in H3K27 altered pediatric pontine diffuse midline gliomas.
J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04347.
PubMed Abstract available

WAGENER K, Beckhaus J, Boekhoff S, Friedrich C, et al
Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
J Neurooncol. 2023 Jul 4. doi: 10.1007/s11060-023-04344.
PubMed Abstract available

LUO M, Tang R, Wang H
Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset.
J Neurooncol. 2023;163:663-674.
PubMed Abstract available

LESKINEN S, Shah HA, Yaffe B, Schneider SJ, et al
Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis.
J Neurooncol. 2023;163:515-527.
PubMed Abstract available

June 2023

JONNAKUTI VS, Ji P, Gao Y, Lin A, et al
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
J Neurooncol. 2023 Jun 30. doi: 10.1007/s11060-023-04370.
PubMed Abstract available

MEISSNER AK, Gutsche R, Galldiks N, Kocher M, et al
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
J Neurooncol. 2023 Jun 29. doi: 10.1007/s11060-023-04367.
PubMed Abstract available

MOORE-PALHARES D, Chen H, Keith J, Wang M, et al
Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol. 2023 Jun 28. doi: 10.1007/s11060-023-04364.
PubMed

ADILE AA, Bakhshinyan D, Suk Y, Uehling D, et al
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
J Neurooncol. 2023 Jun 24. doi: 10.1007/s11060-023-04372.
PubMed Abstract available

HOLDAWAY M, Starner J, Patel RR, Salama J, et al
Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review.
J Neurooncol. 2023 Jun 24. doi: 10.1007/s11060-023-04366.
PubMed Abstract available

CHEN J, Li T, Zhou N, He Y, et al
Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo.
J Neurooncol. 2023 Jun 23. doi: 10.1007/s11060-023-04369.
PubMed Abstract available

TOM MC, DiFilippo FP, Jones SE, Suh JH, et al
(18)F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study.
J Neurooncol. 2023 Jun 21. doi: 10.1007/s11060-023-04377.
PubMed Abstract available

MASSIMINO M, Vennarini S, Buttarelli FR, Antonelli M, et al
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
J Neurooncol. 2023 Jun 16. doi: 10.1007/s11060-023-04361.
PubMed Abstract available

KHAN AB, Patel R, McDonald MF, Goethe E, et al
Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers.
J Neurooncol. 2023 Jun 15. doi: 10.1007/s11060-023-04359.
PubMed Abstract available

JOST J, Muther M, Brandt R, Altuner U, et al
Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience.
J Neurooncol. 2023 Jun 12. doi: 10.1007/s11060-023-04354.
PubMed Abstract available

MERENZON MA, Levy AS, Bhatia S, Rivera C, et al
Towards the definition of progressive disease in brain metastasis treated with laser ablation: an evidence-based study.
J Neurooncol. 2023 Jun 12. doi: 10.1007/s11060-023-04360.
PubMed Abstract available

CHO NS, Sanvito F, Thakuria S, Wang C, et al
Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas.
J Neurooncol. 2023 Jun 9. doi: 10.1007/s11060-023-04363.
PubMed Abstract available

WELLER J, Katzendobler S, Niedermeyer S, Harter PN, et al
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
J Neurooncol. 2023 Jun 8. doi: 10.1007/s11060-023-04362.
PubMed Abstract available

NAGAI N, Koide Y, Shindo Y, Hashimoto S, et al
Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases.
J Neurooncol. 2023 Jun 7. doi: 10.1007/s11060-023-04358.
PubMed Abstract available

TOKLU S, Kemerdere R, Kacira T, Gurses MS, et al
Tissue and plasma free amino acid detection by LC-MS/MS method in high grade glioma patients.
J Neurooncol. 2023 Jun 6. doi: 10.1007/s11060-023-04329.
PubMed Abstract available

MA J, Li D, Hong Y, Zhang Y, et al
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas.
J Neurooncol. 2023 Jun 2. doi: 10.1007/s11060-023-04351.
PubMed Abstract available

VAN SCHIE P, Rijksen BLT, Bot M, Wiersma T, et al
Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
J Neurooncol. 2023 Jun 2. doi: 10.1007/s11060-023-04343.
PubMed Abstract available

CACCESE M, Desideri I, Padovan M, Bruno F, et al
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
J Neurooncol. 2023 Jun 1. doi: 10.1007/s11060-023-04356.
PubMed Abstract available

BISWAS A, Salvucci M, Connor K, Dussmann H, et al
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
J Neurooncol. 2023;163:327-338.
PubMed Abstract available

May 2023

MOORE-PALHARES D, Chen H, Keith J, Wang M, et al
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol. 2023 May 31. doi: 10.1007/s11060-023-04340.
PubMed Abstract available

BANDER ED, Kelly A, Ma X, Christos PJ, et al
Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
J Neurooncol. 2023 May 30. doi: 10.1007/s11060-023-04352.
PubMed Abstract available

MCLAUGHLIN LA, Yildirim O, Rosenblum MK, Imber BS, et al
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT.
J Neurooncol. 2023 May 29. doi: 10.1007/s11060-023-04355.
PubMed Abstract available

SHEEHAN J, Cifarelli CP, Fadul C
Contemporary care for brain metastasis patients: multidisciplinary approaches and the role of prospective national registries.
J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04350.
PubMed

BUSCH N, Wegner RE, Shepard MJ
Letter to the editor: neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04345.
PubMed

TINI P, Yavoroska M, Mazzei MA, Miracco C, et al
Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
J Neurooncol. 2023 May 25. doi: 10.1007/s11060-023-04342.
PubMed Abstract available

JURATLI TA, Jungk C, Miller JJ
Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
J Neurooncol. 2023 May 22. doi: 10.1007/s11060-023-04317.
PubMed

CROOMS RC, Taylor JW, Jette N, Morgenstern R, et al
Palliative care referral across the disease trajectory in high-grade glioma.
J Neurooncol. 2023 May 20. doi: 10.1007/s11060-023-04338.
PubMed Abstract available

FENG X, Zhu F, Dai L, Liu X, et al
Caspase-3 in glioma indicates an unfavorable prognosis by involving surrounding angiogenesis and tumor cell repopulation.
J Neurooncol. 2023 May 17. doi: 10.1007/s11060-023-04339.
PubMed Abstract available

KNIGHT A, Horsley P, Yuile A, Yim J, et al
Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.
J Neurooncol. 2023 May 15. doi: 10.1007/s11060-023-04332.
PubMed Abstract available

VALINCIUTE G, Ecker J, Selt F, Hielscher T, et al
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol. 2023 May 15. doi: 10.1007/s11060-023-04319.
PubMed Abstract available

BONOSI L, Marino S, Benigno UE, Musso S, et al
Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma.
J Neurooncol. 2023 May 14. doi: 10.1007/s11060-023-04333.
PubMed Abstract available

ZILIOLI A, Misirocchi F, Mutti C, Pancaldi B, et al
Volumetric hippocampal changes in glioblastoma: a biomarker for neuroplasticity?
J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04315.
PubMed Abstract available

MA Y, Shi F, Sun T, Chen H, et al
Histopathological auxiliary system for brain tumour (HAS-Bt) based on weakly supervised learning using a WHO CNS5-style pipeline.
J Neurooncol. 2023 May 13. doi: 10.1007/s11060-023-04306.
PubMed Abstract available

MERLIN MS, Schmitt E, Mezloy-Destracque M, Dufour C, et al
Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol.
J Neurooncol. 2023 May 12. doi: 10.1007/s11060-023-04328.
PubMed Abstract available

PADILLA CS, Ho VKY, Mooijenkind TWAN, Louwman MWJ, et al
Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011-2020).
J Neurooncol. 2023 May 12. doi: 10.1007/s11060-023-04335.
PubMed Abstract available

ZABEK T, Szmatola T, Adamczyk-Grochala J, Lewinska A, et al
Knockout of TRDMT1 methyltransferase affects DNA methylome in glioblastoma cells.
J Neurooncol. 2023 May 11. doi: 10.1007/s11060-023-04304.
PubMed Abstract available

KALYVAS A, Gutierrez-Valencia E, Lau R, Ye XY, et al
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery.
J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04325.
PubMed Abstract available

REGLI LKP, Huijs SMH, Pasmans RCOS, Leue C, et al
Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.
J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04326.
PubMed Abstract available

SAUNDERS JT, Kumar S, Benavides-Serrato A, Holmes B, et al
Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET.
J Neurooncol. 2023 May 10. doi: 10.1007/s11060-023-04331.
PubMed Abstract available

LAZZARINI E, Silvestris DA, Benvenuto G, Osti D, et al
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
J Neurooncol. 2023 May 4. doi: 10.1007/s11060-023-04287.
PubMed Abstract available

ZUO P, Li Y, Wang T, Lin X, et al
A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma.
J Neurooncol. 2023 May 3. doi: 10.1007/s11060-023-04323.
PubMed Abstract available

FISHMAN H, Monin R, Dor-On E, Kinzel A, et al
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines.
J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04308.
PubMed Abstract available

TRAVERS SS, Fisher CM, Kabos P, Cittelly DM, et al
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience.
J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04314.
PubMed Abstract available

DE GODOY LL, Chawla S, Brem S, Wang S, et al
Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.
J Neurooncol. 2023 May 2. doi: 10.1007/s11060-023-04324.
PubMed Abstract available

YE L, Wu BS, Xu ZA, Ji XF, et al
Evidence for an intra-tumoral microbiome in pituitary neuroendocrine tumors with different clinical phenotypes.
J Neurooncol. 2023;163:133-142.
PubMed Abstract available

DEWAN MC, Isaacs AM, Cools MJ, Yengo-Kahn A, et al
Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research Network.
J Neurooncol. 2023;163:123-132.
PubMed Abstract available

LI Q, Ma Y, Lin Z, Ma J, et al
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma.
J Neurooncol. 2023;163:39-46.
PubMed Abstract available

April 2023

AMELOT A, Terrier LM, Cognacq G, Jecko V, et al
Correction to: Natural history of spinal cord metastasis from brain glioblastomas.
J Neurooncol. 2023 Apr 26. doi: 10.1007/s11060-023-04320.
PubMed

SENGUPTA S
Integrative neuro-oncology for brain tumor patients.
J Neurooncol. 2023 Apr 25. doi: 10.1007/s11060-023-04309.
PubMed

CHANG WH, Wei KC, Chen PY, Chen YC, et al
The impact of patient factors and tumor characteristics on language neuroplasticity in left hemispheric diffuse gliomas prior to surgical resection.
J Neurooncol. 2023 Apr 24. doi: 10.1007/s11060-023-04311.
PubMed Abstract available

TRACZ JA, Donnelly BM, Ngu S, Vojnic M, et al
The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma.
J Neurooncol. 2023 Apr 22. doi: 10.1007/s11060-023-04312.
PubMed Abstract available

SYED HR, Kilburn L, Fonseca A, Nazarian J, et al
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication.
J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04269.
PubMed

DEMETZ M, Krigers A, Moser P, Kerschbaumer J, et al
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival.
J Neurooncol. 2023 Apr 12. doi: 10.1007/s11060-023-04301.
PubMed Abstract available

ALTIERI R, Certo F, Pacella D, Cammarata G, et al
Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
J Neurooncol. 2023 Apr 11. doi: 10.1007/s11060-023-04305.
PubMed Abstract available

VOON NS, Manan HA, Yahya N
Remote assessment of cognition and quality of life following radiotherapy for glioma: deep-learning-based predictive models and MRI correlates.
J Neurooncol. 2023 Apr 4:1-9. doi: 10.1007/s11060-023-04303.
PubMed Abstract available

DINCER A, Morales-Valero SF, Robert SM, Tabor JK, et al
Surgical strategies for intracranial meningioma in the molecular era.
J Neurooncol. 2023 Apr 3. doi: 10.1007/s11060-023-04272.
PubMed Abstract available

YAMASHITA S, Takeshima H, Hata N, Uchida H, et al
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
J Neurooncol. 2023;162:425-433.
PubMed Abstract available

FOO JC, Yaman Bajin I, Marushchak O, McKeown T, et al
Time to dismiss boost? Outcomes of children with localized and metastatic germinoma.
J Neurooncol. 2023;162:443-448.
PubMed Abstract available

ROEHRIG A, Indelicato DJ, Paulino AC, Ermoian R, et al
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
J Neurooncol. 2023;162:353-362.
PubMed Abstract available

KEARNS K, Shepard MJ, Sheehan JP
Social media and the Journal of Neuro-Oncology.
J Neurooncol. 2023;162:453-454.
PubMed

March 2023

AYMERIC A, Louis-Marie T, Gabrielle C, Vincent J, et al
Natural history of spinal cord metastasis from brain glioblastomas.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04298.
PubMed Abstract available

QUAN G, Wang T, Ren JL, Xue X, et al
Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04299.
PubMed Abstract available

CHAMPEAUX-DEPOND C, Jecko V, Weller J, Constantinou P, et al
Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04295.
PubMed Abstract available

OZKARA BB, Federau C, Dagher SA, Pattnaik D, et al
Correlating volumetric and linear measurements of brain metastases on MRI scans using intelligent automation software: a preliminary study.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04297.
PubMed Abstract available

ZHA B, Yang J, Dang Q, Li P, et al
A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma.
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04292.
PubMed Abstract available

POPPE JP, Schwartz C
In reply to the letter to the editor by Busch et al. regarding "Surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study".
J Neurooncol. 2023 Mar 29. doi: 10.1007/s11060-023-04302.
PubMed

KIMURA K, Deguchi S, Mitsuya K, Mamesaya N, et al
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
J Neurooncol. 2023 Mar 28. doi: 10.1007/s11060-023-04300.
PubMed Abstract available

WAMELINK IJHG, Hempel HL, van de Giessen E, Vries MHM, et al
The patients' experience of neuroimaging of primary brain tumors: a cross-sectional survey study.
J Neurooncol. 2023 Mar 28. doi: 10.1007/s11060-023-04290.
PubMed Abstract available

IUS T, Sabatino G, Panciani PP, Fontanella MM, et al
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch(R)): a systematic review.
J Neurooncol. 2023 Mar 24. doi: 10.1007/s11060-023-04274.
PubMed Abstract available

PARSONS MW, Sabsevitz DS
Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology.
J Neurooncol. 2023 Mar 20. doi: 10.1007/s11060-023-04289.
PubMed Abstract available

LIANG L, Wen L, Qin S, He Z, et al
Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study.
J Neurooncol. 2023 Mar 20. doi: 10.1007/s11060-023-04293.
PubMed Abstract available

SHAH DS, Reddy RV, Dogruel Y, Asfour MZ, et al
Calcified spinal meningiomas: a systematic review of clinical characteristics, treatment strategies, and outcomes.
J Neurooncol. 2023 Mar 17. doi: 10.1007/s11060-023-04291.
PubMed Abstract available

QUACH S, Schwartz C, Aumiller M, Foglar M, et al
Interstitial photodynamic therapy for newly diagnosed glioblastoma.
J Neurooncol. 2023 Mar 16. doi: 10.1007/s11060-023-04284.
PubMed Abstract available

BLEEKER L, Kouwenhoven MCM, de Heer I, Lissenberg-Witte BI, et al
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
J Neurooncol. 2023 Mar 15. doi: 10.1007/s11060-023-04285.
PubMed Abstract available

YAN M, Lee M, Myrehaug S, Tseng CL, et al
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04265.
PubMed Abstract available

DUFFAU H
Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04288.
PubMed Abstract available

KING AL, Roche KN, Leeper HE, Vera E, et al
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
J Neurooncol. 2023 Mar 8:1-9. doi: 10.1007/s11060-023-04271.
PubMed Abstract available

JUSINO S, Fadul CE, Dillon P
Systematic review of the management of brain metastases from hormone receptor positive breast cancer.
J Neurooncol. 2023 Mar 8. doi: 10.1007/s11060-023-04276.
PubMed Abstract available

TRIFILETTI DM, Akinyelu T, Burri SH, Jeudy A, et al
Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety.
J Neurooncol. 2023 Mar 6. doi: 10.1007/s11060-023-04278.
PubMed

MARTIN JA, Hart NH, Bradford N, Naumann F, et al
Prevalence and management of sleep disturbance in adults with primary brain tumours and their caregivers: a systematic review.
J Neurooncol. 2023 Mar 2. doi: 10.1007/s11060-023-04270.
PubMed Abstract available

LI C, Guan N, Liu F
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
J Neurooncol. 2023 Mar 1. doi: 10.1007/s11060-023-04257.
PubMed Abstract available

THIERHEIMER M, Cioffi G, Waite KA, Kruchko C, et al
Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex.
J Neurooncol. 2023;162:167-177.
PubMed Abstract available

SHARMA M, Do TH, Palzer EF, Huling JD, et al
Comparable safety profile between neuro-oncology procedures involving stereotactic needle biopsy (SNB) followed by laser interstitial thermal therapy (LITT) and LITT alone procedures.
J Neurooncol. 2023;162:147-156.
PubMed Abstract available

WEI Z, Pease M, Tang LW, Deng H, et al
Radiosurgery outcomes in infratentorial juvenile pilocytic astrocytomas.
J Neurooncol. 2023;162:157-165.
PubMed Abstract available

CACCIOTTI C, Chua IS, Cuadra J, Ullrich NJ, et al
Pediatric central nervous system tumor survivor and caregiver experiences with multidisciplinary telehealth.
J Neurooncol. 2023;162:191-198.
PubMed Abstract available

WESSELS PH, Boelens MC, Monkhorst K, Sonke GS, et al
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?
J Neurooncol. 2023;162:1-13.
PubMed Abstract available

February 2023

TRINGALE KR, Wolden SL, Karajannis M, Haque S, et al
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
J Neurooncol. 2023 Feb 28. doi: 10.1007/s11060-022-04235.
PubMed Abstract available

MOLITERNO J, Brastianos PK
Journal of Neuro-Oncology, Meningioma issue.
J Neurooncol. 2023 Feb 27. doi: 10.1007/s11060-023-04251.
PubMed

PARK YW, Han K, Kim S, Kwon H, et al
Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities.
J Neurooncol. 2023 Feb 25. doi: 10.1007/s11060-022-04233.
PubMed Abstract available

WANG JZ, Nassiri F, Landry AP, Patil V, et al
The multiomic landscape of meningiomas: a review and update.
J Neurooncol. 2023 Feb 25. doi: 10.1007/s11060-023-04253.
PubMed Abstract available

DE CASTRO DG, Sanematsu PI Jr, Pellizzon ACA, Suzuki SH, et al
Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial.
J Neurooncol. 2023 Feb 24. doi: 10.1007/s11060-023-04266.
PubMed Abstract available

PEI J, Li P, Gao YH, Tian BG, et al
Type IV collagen-derived angiogenesis inhibitor: canstatin low expressing in brain-invasive meningiomas using liquid chromatography-mass spectrometry (LC-MS/MS).
J Neurooncol. 2023 Feb 22. doi: 10.1007/s11060-023-04256.
PubMed Abstract available

UHLMANN EJ, Mackel CE, Deforzh E, Rabinovsky R, et al
Inhibition of the epigenetically activated miR-483-5p/IGF-2 pathway results in rapid loss of meningioma tumor cell viability.
J Neurooncol. 2023 Feb 21. doi: 10.1007/s11060-023-04264.
PubMed Abstract available

BUSCH N, Zaki PG, Shepard MJ
Letter to the editor: surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study.
J Neurooncol. 2023 Feb 21. doi: 10.1007/s11060-023-04267.
PubMed

NASRALLAH MP, Aldape KD
Molecular classification and grading of meningioma.
J Neurooncol. 2023 Feb 18. doi: 10.1007/s11060-022-04228.
PubMed Abstract available

ORTIZ-RIVERA J, Nunez R, Kucheryavykh Y, Kucheryavykh L, et al
The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model.
J Neurooncol. 2023 Feb 15. doi: 10.1007/s11060-023-04260.
PubMed Abstract available

GHODRATI F, Mekonnen M, Mahgerefteh N, Zhang AB, et al
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection.
J Neurooncol. 2023 Feb 14. doi: 10.1007/s11060-023-04259.
PubMed Abstract available

HUYNH KA, Coopmans EC, Zamanipoor Najafabadi AH, Dirven L, et al
Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up.
J Neurooncol. 2023 Feb 13. doi: 10.1007/s11060-023-04255.
PubMed

SCHRAMM MWJ, Currie S, Lee MT, Livermore LJ, et al
Do animal models of brain tumors replicate human peritumoral edema? a systematic literature search.
J Neurooncol. 2023 Feb 9. doi: 10.1007/s11060-023-04246.
PubMed Abstract available

HEINZEL A, Mottaghy FM, Filss C, Stoffels G, et al
The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis.
J Neurooncol. 2023 Feb 7. doi: 10.1007/s11060-023-04254.
PubMed Abstract available

MELHEM JM, Tahir A, Calabrese E, Granovskaya I, et al
Dose-dependent efficacy of bevacizumab in recurrent glioblastoma.
J Neurooncol. 2023 Feb 7. doi: 10.1007/s11060-023-04248.
PubMed Abstract available

FUKUYA Y, Tamura M, Nitta M, Saito T, et al
Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas.
J Neurooncol. 2023 Feb 7. doi: 10.1007/s11060-023-04244.
PubMed Abstract available

WITTEN AJ, Ben-Shalom N, Ellis JA, Boockvar JA, et al
Optimization of novel exoscopic blue light filter during fluorescence-guided resection of Glioblastoma.
J Neurooncol. 2023 Feb 6. doi: 10.1007/s11060-022-04231.
PubMed Abstract available

SPECKTER H, Palque-Santos S, Mota-Gonzalez R, Bido J, et al
Can Apparent Diffusion Coefficient (ADC) maps replace Diffusion Tensor Imaging (DTI) maps to predict the volumetric response of meningiomas to Gamma Knife Radiosurgery?
J Neurooncol. 2023 Feb 6. doi: 10.1007/s11060-023-04243.
PubMed Abstract available

PERWEIN T, Giese B, Nussbaumer G, von Bueren AO, et al
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study.
J Neurooncol. 2023 Feb 1. doi: 10.1007/s11060-023-04241.
PubMed Abstract available

PATEL Z, Cho M, Das S
The role of immune checkpoint inhibitors in patients with intracranial metastatic disease.
J Neurooncol. 2023;161:469-478.
PubMed Abstract available

AK M, Lf N, Gm I, Av K, et al
Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.
J Neurooncol. 2023;161:573-582.
PubMed Abstract available

January 2023

POPPE JP, Machegger L, Steinbacher J, Stefanits H, et al
Surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study.
J Neurooncol. 2023 Jan 31. doi: 10.1007/s11060-023-04252.
PubMed Abstract available

DADARIO NB, Ivan M, Sughrue ME
Standardizing connectome-based brain tumor surgery through a network-based surgical nomenclature.
J Neurooncol. 2023 Jan 31. doi: 10.1007/s11060-023-04249.
PubMed

REUSS DE
Updates on the WHO diagnosis of IDH-mutant glioma.
J Neurooncol. 2023 Jan 30. doi: 10.1007/s11060-023-04250.
PubMed Abstract available

POTTHOFF AL, Heimann M, Lehmann F, Ilic I, et al
Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease.
J Neurooncol. 2023 Jan 25. doi: 10.1007/s11060-023-04242.
PubMed Abstract available

COPPIETERS N, Scalisi J, Digregorio M, Leparc L, et al
Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma.
J Neurooncol. 2023 Jan 25. doi: 10.1007/s11060-023-04240.
PubMed Abstract available

HOLTZMAN AL, Glassman GE, Dagan R, Rao D, et al
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma.
J Neurooncol. 2023 Jan 24. doi: 10.1007/s11060-022-04207.
PubMed Abstract available

GIUSSANI C, Carrabba G, Rui CB, Chiarello G, et al
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience.
J Neurooncol. 2023 Jan 23. doi: 10.1007/s11060-022-04232.
PubMed Abstract available

HALKETT GKB, Lobb EA, Phillips JL, McDougall E, et al
Carer preparedness improved by providing a supportive educational intervention for carers of patients with high-grade glioma: RCT results.
J Neurooncol. 2023 Jan 19. doi: 10.1007/s11060-023-04239.
PubMed Abstract available

DAO TRONG P, Gluszak M, Reuss D, von Deimling A, et al
Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort.
J Neurooncol. 2023 Jan 17. doi: 10.1007/s11060-022-04230.
PubMed Abstract available

ELSAMADICY AA, Reeves BC, Craft S, Sherman JJZ, et al
A current review of spinal meningiomas: epidemiology, clinical presentation and management.
J Neurooncol. 2023 Jan 13. doi: 10.1007/s11060-023-04238.
PubMed Abstract available

WIJAYA JH, July J, Quintero-Consuegra M, Chadid DP, et al
A systematic review and meta-analysis of the effects of tranexamic acid in surgical procedure for intracranial meningioma.
J Neurooncol. 2023 Jan 12. doi: 10.1007/s11060-023-04237.
PubMed Abstract available

SILVERSTEIN JW, Shah HA, Unadkat P, Vilaysom S, et al
Short and long-term prognostic value of intraoperative motor evoked potentials in brain tumor patients: a case series of 121 brain tumor patients.
J Neurooncol. 2023 Jan 11. doi: 10.1007/s11060-022-04229.
PubMed Abstract available

HUYNH KA, Coopmans EC, Najafabadi AHZ, Dirven L, et al
Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up.
J Neurooncol. 2023 Jan 10. doi: 10.1007/s11060-022-04223.
PubMed Abstract available

LEHMAN NL
Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
J Neurooncol. 2023 Jan 6. doi: 10.1007/s11060-022-04222.
PubMed Abstract available

EICHKORN T, Lischalk JW, Horner-Rieber J, Deng M, et al
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
J Neurooncol. 2023 Jan 4. doi: 10.1007/s11060-022-04217.
PubMed Abstract available

SUAREZ-MEADE P, Watanabe F, Ruiz-Garcia H, Rafferty SB, et al
SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models.
J Neurooncol. 2023 Jan 3:1-10. doi: 10.1007/s11060-022-04205.
PubMed Abstract available

MAYO ZS, Halima A, Broughman JR, Smile TD, et al
Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis.
J Neurooncol. 2023;161:23-31.
PubMed Abstract available

LIN YY, Wu HM, Yang HC, Chen CJ, et al
Stereotactic radiosurgery for pituitary and cavernous sinus metastases.
J Neurooncol. 2023;161:175-184.
PubMed Abstract available

JOHNSON KJ, Barnes JM, Delavar A, O'Connell CP, et al
Facility patient volume and survival among individuals diagnosed with malignant central nervous system tumors.
J Neurooncol. 2023;161:117-126.
PubMed Abstract available

WELLER J, Schafer N, Schaub C, Tzaridis T, et al
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.
J Neurooncol. 2023;161:147-153.
PubMed Abstract available

KUMAR S, Islim AI, Moon R, Millward CP, et al
Long term quality of life outcomes following surgical resection alone for benign paediatric intracranial tumours.
J Neurooncol. 2023;161:77-84.
PubMed Abstract available

BUTENSCHOEN VM, Schwendner M, Hubertus V, Onken J, et al
Preoperative angiographic considerations and neurological outcome after surgical treatment of intradural spinal hemangioblastoma: a multicenter retrospective case series.
J Neurooncol. 2023;161:107-115.
PubMed Abstract available

CARLOS-ESCALANTE JA, Mejia-Perez SI, Soto-Reyes E, Guerra-Calderas L, et al
Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker.
J Neurooncol. 2023;161:165-174.
PubMed Abstract available

December 2022

QIU X, Gao J, Hu J, Yang J, et al
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.
J Neurooncol. 2022 Dec 30. doi: 10.1007/s11060-022-04202.
PubMed Abstract available

SLOAN AE, Nock CJ, Ye X, Buerki R, et al
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
J Neurooncol. 2022 Dec 29. doi: 10.1007/s11060-022-04193.
PubMed Abstract available

SOMMA T, Bove I, Vitulli F, Cappabianca P, et al
Management and treatment of brain tumors during pregnancy: an Italian survey.
J Neurooncol. 2022 Dec 29. doi: 10.1007/s11060-022-04215.
PubMed Abstract available

WOLLRING MM, Werner JM, Ceccon G, Lohmann P, et al
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas.
J Neurooncol. 2022 Dec 29. doi: 10.1007/s11060-022-04218.
PubMed Abstract available

HOPPER A, Salans M, Karunamuni R, Hattangadi-Gluth JA, et al
Neurocognitive considerations in the treatment of meningioma with radiation therapy: applications for quantitative neuroimaging and precision radiation medicine.
J Neurooncol. 2022 Dec 26. doi: 10.1007/s11060-022-04175.
PubMed Abstract available

ENTENMANN CJ, Bubenikova A, Blazkova J Jr, Zapotocky M, et al
Evaluation of the growth rates and related prognostic factors in radiation-induced meningiomas.
J Neurooncol. 2022 Dec 24. doi: 10.1007/s11060-022-04209.
PubMed Abstract available

SINGH J, Sharma R, Shukla N, Narwal P, et al
DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
J Neurooncol. 2022 Dec 24. doi: 10.1007/s11060-022-04220.
PubMed Abstract available

USUZAKI T, Takahashi K
Comment on "Sex as a prognostic factor in adultâ€‘type diffuse gliomas: an integrated clinical and molecular analysis according to 2021 WHO classification".
J Neurooncol. 2022 Dec 22. doi: 10.1007/s11060-022-04224.
PubMed

LIU CW, Yang HC, Chiang CL, Shen CI, et al
Leukoencephalopathy in patients with brain metastases who received radiosurgery with or without whole brain radiotherapy.
J Neurooncol. 2022 Dec 22. doi: 10.1007/s11060-022-04210.
PubMed Abstract available

KESHWARA SM, Gillespie CS, Mustafa MA, George AM, et al
Quality of life outcomes in incidental and operated meningiomas (QUALMS): a cross-sectional cohort study.
J Neurooncol. 2022 Dec 16. doi: 10.1007/s11060-022-04198.
PubMed Abstract available

SHI W, Wang Y, Xia W, Liu B, et al
Brain metastases from small cell lung cancer and non-small cell lung cancer: comparison of spatial distribution and identification of metastatic risk regions.
J Neurooncol. 2022 Dec 15. doi: 10.1007/s11060-022-04211.
PubMed Abstract available

STEINER G, Galli R, Preusse G, Michen S, et al
A new approach for clinical translation of infrared spectroscopy: exploitation of the signature of glioblastoma for general brain tumor recognition.
J Neurooncol. 2022 Dec 12. doi: 10.1007/s11060-022-04204.
PubMed Abstract available

THOMMEN R, Kazim SF, Rumalla K, Kassicieh AJ, et al
Correction to: Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis.
J Neurooncol. 2022 Dec 12. doi: 10.1007/s11060-022-04212.
PubMed

SINGNURKAR A, Poon R, Detsky J
18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysis.
J Neurooncol. 2022 Dec 11. doi: 10.1007/s11060-022-04201.
PubMed Abstract available

CHEN YC, Yang HC, Chiang CL, Chen CJ, et al
Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical center.
J Neurooncol. 2022 Dec 5. doi: 10.1007/s11060-022-04153.
PubMed Abstract available

KIM D, Chang WI, Byun HK, Kim IA, et al
Dose-response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy.
J Neurooncol. 2022 Dec 5. doi: 10.1007/s11060-022-04206.
PubMed Abstract available

ALBERS EAC, de Ruiter MB, van de Poll-Franse LV, Merckel LG, et al
Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
J Neurooncol. 2022 Dec 1. doi: 10.1007/s11060-022-04185.
PubMed Abstract available

CHOJAK R, Kozba-Gosztyla M, Polanska K, Rojek M, et al
Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
J Neurooncol. 2022;160:753-761.
PubMed Abstract available

PENNINGTON Z, Mikula AL, Lakomkin N, Meyer FB, et al
Impact of tumor-associated syrinx on outcomes following resection of primary ependymomas of the spinal cord.
J Neurooncol. 2022;160:725-733.
PubMed Abstract available

TOMASINO B, Guarracino I, Pauletto G, Pez S, et al
Performing real time neuropsychological testing during awake craniotomy: are dexmedetomidine or propofol the same? A preliminary report.
J Neurooncol. 2022;160:707-716.
PubMed Abstract available

SLEURS C, Zegers CML, Compter I, Dijkstra J, et al
Neurocognition in adults with intracranial tumors: does location really matter?
J Neurooncol. 2022;160:619-629.
PubMed Abstract available

November 2022

KIM W, Ghodrati F, Mozaffari K, Samarage HM, et al
Endoscopic endonasal approach for resection of a recurrent spheno-orbital meningioma resulting in complete resolution of visual symptoms: A case report and review of literature.
J Neurooncol. 2022 Nov 29. doi: 10.1007/s11060-022-04141.
PubMed Abstract available

KHRISTOV V, Nesterova D, Trifoi M, Clegg T, et al
Plasma IL13Ralpha2 as a novel liquid biopsy biomarker for glioblastoma.
J Neurooncol. 2022 Nov 27. doi: 10.1007/s11060-022-04196.
PubMed Abstract available

VASAN V, Dullea JT, Devarajan A, Ali M, et al
NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
J Neurooncol. 2022 Nov 27. doi: 10.1007/s11060-022-04197.
PubMed Abstract available

SVENJEBY C, Carstam L, Werlenius K, Bontell TO, et al
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period.
J Neurooncol. 2022 Nov 25. doi: 10.1007/s11060-022-04136.
PubMed Abstract available

ROACH JR, Plaha P, McGowan DR, Higgins GS, et al
The role of [(18)F]fluorodopa positron emission tomography in grading of gliomas.
J Neurooncol. 2022 Nov 24. doi: 10.1007/s11060-022-04177.
PubMed Abstract available

MIYAGISHIMA DF, Moliterno J, Claus E, Gunel M, et al
Hormone therapies in meningioma-where are we?
J Neurooncol. 2022 Nov 23. doi: 10.1007/s11060-022-04187.
PubMed Abstract available

ELSHEIKH M, Bridgman E, Lavrador JP, Lammy S, et al
Association of extent of resection and functional outcomes in diffuse low-grade glioma: systematic review & meta-analysis.
J Neurooncol. 2022 Nov 21. doi: 10.1007/s11060-022-04192.
PubMed Abstract available

KIM SJ, Park SJ, Park J, Cho HJ, et al
Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres.
J Neurooncol. 2022 Nov 17. pii: 10.1007/s11060-022-04189.
PubMed Abstract available

GAMBOA NT, Crabb B, Henson JC, Cole KL, et al
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI.
J Neurooncol. 2022 Nov 17. pii: 10.1007/s11060-022-04159.
PubMed Abstract available

TEN CATE C, Huijs SMH, Willemsen ACH, Pasmans RCOS, et al
Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients.
J Neurooncol. 2022 Nov 17. pii: 10.1007/s11060-022-04180.
PubMed Abstract available

ISLIM AI, Lee JX, Mustafa MA, Millward CP, et al
Sporadic multiple intracranial meningioma does not infer worse patient outcomes: results from a case control study.
J Neurooncol. 2022 Nov 15. pii: 10.1007/s11060-022-04184.
PubMed Abstract available

RAJKUMAR S, Liang Y, Wegner RE, Shepard MJ, et al
Utilization of neoadjuvant stereotactic radiosurgery for the treatment of brain metastases requiring surgical resection: a topic review.
J Neurooncol. 2022 Nov 14. pii: 10.1007/s11060-022-04190.
PubMed Abstract available

SHAH HA, Leskinen S, Khilji H, Narayan V, et al
Utility of 5-ALA for fluorescence-guided resection of brain metastases: a systematic review.
J Neurooncol. 2022 Nov 12. pii: 10.1007/s11060-022-04188.
PubMed Abstract available

SATRAGNO C, Verrico A, Giannelli F, Ferrero A, et al
High dose craniospinal irradiation as independent risk factor of permanent alopecia in childhood medulloblastoma survivors: cohort study and literature review.
J Neurooncol. 2022 Nov 12. pii: 10.1007/s11060-022-04186.
PubMed Abstract available

WANG J, Huang Y, Zhao F, Chen J, et al
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
J Neurooncol. 2022 Nov 10. pii: 10.1007/s11060-022-04162.
PubMed Abstract available

CHIDLEY P, Shanker M, Phillips C, Haghighi N, et al
Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature.
J Neurooncol. 2022 Nov 10. pii: 10.1007/s11060-022-04151.
PubMed Abstract available

ALI AS, Lombardo J, Niazi MZ, Miller RC, et al
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
J Neurooncol. 2022 Nov 10. pii: 10.1007/s11060-022-04146.
PubMed Abstract available

QUIJANO-RUBIO C, Silginer M, Weller M
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
J Neurooncol. 2022 Nov 10. pii: 10.1007/s11060-022-04137.
PubMed Abstract available

SHI DD, Anand S, Abdullah KG, McBrayer SK, et al
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications.
J Neurooncol. 2022 Nov 9. pii: 10.1007/s11060-022-04172.
PubMed Abstract available

ZHOU S, Ren F, Li C, Jiang L, et al
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study.
J Neurooncol. 2022 Nov 8. pii: 10.1007/s11060-022-04182.
PubMed Abstract available

MADER MM, Deuter D, Sauvigny T, Borchert P, et al
Diffusion tensor imaging changes in patients with glioma-associated seizures.
J Neurooncol. 2022 Nov 7. pii: 10.1007/s11060-022-04139.
PubMed Abstract available

ROY LO, Lemelin M, Blanchette M, Poirier MB, et al
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates.
J Neurooncol. 2022 Nov 7. pii: 10.1007/s11060-022-04179.
PubMed Abstract available

LANIER CM, Pearce J, Isom S, Xing F, et al
Long term survivors of stereotactic radiosurgery for brain metastases: do distant brain failures reach a plateau and what factors are associated with a brain metastasis velocity of zero?
J Neurooncol. 2022 Nov 6. pii: 10.1007/s11060-022-04183.
PubMed Abstract available

HUA L, Ren L, Wu Q, Deng J, et al
Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk.
J Neurooncol. 2022 Nov 3. pii: 10.1007/s11060-022-04169.
PubMed Abstract available

BRAUCHITSCH SV, Strzelczyk A, Rosenow F, Neuhaus E, et al
High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors.
J Neurooncol. 2022 Nov 3. pii: 10.1007/s11060-022-04133.
PubMed Abstract available

GALLET C, Clavreul A, Morandi X, Delion M, et al
What surgical approach for left-sided eloquent glioblastoma: biopsy, resection under general anesthesia or awake craniotomy?
J Neurooncol. 2022 Nov 3. pii: 10.1007/s11060-022-04163.
PubMed Abstract available

CHOTAI S, Tang AR, Gupta R, Guidry BS, et al
Matched case-control analysis of outcomes following surgical resection of incidental meningioma.
J Neurooncol. 2022 Nov 3. pii: 10.1007/s11060-022-04167.
PubMed Abstract available

ZENG L, Li H, Chen R, Yang H, et al
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis.
J Neurooncol. 2022 Nov 2. pii: 10.1007/s11060-022-04170.
PubMed Abstract available

GORODEZKI D, Zipfel J, Queudeville M, Sosa J, et al
Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis.
J Neurooncol. 2022 Nov 1. pii: 10.1007/s11060-022-04176.
PubMed Abstract available

MCKENZIE G, Gaskins J, Rattani A, Oliver A, et al
Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases.
J Neurooncol. 2022 Nov 1. pii: 10.1007/s11060-022-04178.
PubMed Abstract available

JIA H, Zhang P, Gu G, Li T, et al
Brainstem tumors may increase the impairment of behavioral emotional cognition in children.
J Neurooncol. 2022;160:423-432.
PubMed Abstract available

IGLESIAS P, Biagetti B, Araujo-Castro M, Alcazar V, et al
Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
J Neurooncol. 2022;160:351-359.
PubMed Abstract available

RAGHIB MF, Salim A, Angez M, Ghazi SM, et al
Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma.
J Neurooncol. 2022;160:491-496.
PubMed Abstract available

SHE L, Deng D, Su L, Liu C, et al
Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
J Neurooncol. 2022;160:455-462.
PubMed Abstract available

WEBB M, Johnson DR, Mahajan A, Brown P, et al
Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
J Neurooncol. 2022;160:527-534.
PubMed Abstract available

October 2022

THOMMEN R, Kazim SF, Rumalla K, Kassicieh AJ, et al
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis.
J Neurooncol. 2022 Oct 31. pii: 10.1007/s11060-022-04135.
PubMed Abstract available

CHEN WC, Perlow HK, Choudhury A, Nguyen MP, et al
Radiotherapy for meningiomas.
J Neurooncol. 2022 Oct 31. pii: 10.1007/s11060-022-04171.
PubMed Abstract available

RUDA R, Bruno F, Pellerino A, Pronello E, et al
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
J Neurooncol. 2022 Oct 30. pii: 10.1007/s11060-022-04155.
PubMed Abstract available

TSUJI S, Nakamura S, Shoda K, Yamada T, et al
NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.
J Neurooncol. 2022 Oct 29. pii: 10.1007/s11060-022-04154.
PubMed Abstract available

SHARMA M, Wang D, Palmisciano P, Ugiliweneza B, et al
Is intraoperative MRI use in malignant brain tumor surgery a health care burden? A matched analysis of MarketScan Database.
J Neurooncol. 2022 Oct 26. pii: 10.1007/s11060-022-04142.
PubMed Abstract available

OHNO M, Kitano S, Satomi K, Yoshida A, et al
Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas.
J Neurooncol. 2022 Oct 25. pii: 10.1007/s11060-022-04165.
PubMed Abstract available

BATTISTA F, Muscas G, Dinoi F, Gadda D, et al
Ventricular entry during surgical resection is associated with intracranial leptomeningeal dissemination in glioblastoma patients.
J Neurooncol. 2022 Oct 23. pii: 10.1007/s11060-022-04166.
PubMed Abstract available

CARSTAM L, Ryden I, Jakola AS
Seizures in patients with IDH-mutated lower grade gliomas.
J Neurooncol. 2022 Oct 18. pii: 10.1007/s11060-022-04158.
PubMed Abstract available

MAHMOODIFAR S, Pangal DJ, Cardinal T, Craig D, et al
A quantitative characterization of the spatial distribution of brain metastases from breast cancer and respective molecular subtypes.
J Neurooncol. 2022 Oct 16. pii: 10.1007/s11060-022-04147.
PubMed Abstract available

PEASE M, Gersey ZC, Ak M, Elakkad A, et al
Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.
J Neurooncol. 2022 Oct 14. pii: 10.1007/s11060-022-04150.
PubMed Abstract available

HUI C, Qu V, Wang JY, von Eyben R, et al
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer.
J Neurooncol. 2022 Oct 13. pii: 10.1007/s11060-022-04145.
PubMed Abstract available

MARQUEZ J, Schmidt M, Bowers CA
Letter: Does the "hospital frailty risk score" measure preoperative frailty for craniopharyngioma surgery?
J Neurooncol. 2022 Oct 12. pii: 10.1007/s11060-022-04157.
PubMed

RAZAVIAN NB, Helis CA, Laxton A, Tatter S, et al
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery.
J Neurooncol. 2022 Oct 12. pii: 10.1007/s11060-022-04156.
PubMed Abstract available

LU G, Zhu P, Rao M, Linendoll N, et al
Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab.
J Neurooncol. 2022 Oct 6. pii: 10.1007/s11060-022-04144.
PubMed Abstract available

MAIR MJ, Berghoff AS, Brastianos PK, Preusser M, et al
Emerging systemic treatment options in meningioma.
J Neurooncol. 2022 Oct 1. pii: 10.1007/s11060-022-04148.
PubMed Abstract available

CIOFFI G, Waite KA, Edelson JL, Kruchko C, et al
Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017.
J Neurooncol. 2022;160:209-219.
PubMed Abstract available

WELLER J, Katzendobler S, Blobner J, Thiele F, et al
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.
J Neurooncol. 2022;160:149-158.
PubMed Abstract available

SURUGA Y, Satomi K, Otani Y, Fujii K, et al
The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology.
J Neurooncol. 2022;160:179-189.
PubMed Abstract available

MALAIZE H, Laigle-Donadey F, Riche M, Marijon P, et al
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion.
J Neurooncol. 2022;160:159-170.
PubMed Abstract available

HONG KT, Han JW, Fuji H, Byun HK, et al
Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
J Neurooncol. 2022;160:41-53.
PubMed Abstract available

PALMISCIANO P, Watanabe G, Conching A, Ogasawara C, et al
Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
J Neurooncol. 2022;160:79-100.
PubMed Abstract available

September 2022

ABDALLAH HM, Mallela AN, Wei Z, Abou-Al-Shaar H, et al
Gamma Knife radiosurgery for meningiomas of the confluence of the falx and tentorium.
J Neurooncol. 2022 Sep 20. pii: 10.1007/s11060-022-04125.
PubMed Abstract available

KOIDE Y, Nagai N, Miyauchi R, Kitagawa T, et al
Radiotherapy or systemic therapy versus combined therapy in patients with brain metastases: a propensity-score matched study.
J Neurooncol. 2022 Sep 16. pii: 10.1007/s11060-022-04132.
PubMed Abstract available

SCHACKERT G, Lenk M, Kirsch M, Hennig S, et al
Surgical results of 158 petroclival meningiomas with special focus on standard craniotomies.
J Neurooncol. 2022 Sep 14. pii: 10.1007/s11060-022-04105.
PubMed Abstract available

SU H, Hailin Z, Dongdong L, Jiang Y, et al
Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p.
J Neurooncol. 2022 Sep 12. pii: 10.1007/s11060-022-04113.
PubMed Abstract available

LU VM, Niazi TN
Racial disparities in pediatric malignant glioma management: current state of affairs in the United States.
J Neurooncol. 2022 Sep 8. pii: 10.1007/s11060-022-04130.
PubMed Abstract available

ABDELRAHMAN A, Negroni C, Sahm F, Adams CL, et al
miR-497 and 219 in blood aid meningioma classification.
J Neurooncol. 2022 Sep 8. pii: 10.1007/s11060-022-04126.
PubMed Abstract available

SAMOYEAU T, Provost C, Roux A, Legrand L, et al
Meningioma in patients exposed to progestin drugs: results from a real-life screening program.
J Neurooncol. 2022 Sep 6. pii: 10.1007/s11060-022-04124.
PubMed Abstract available

DOS SANTOS SILVA J, Schreiner CA, de Lima L, Brigido CEPL, et al
Volumetric measurement of intracranial meningiomas: a comparison between linear, planimetric, and machine learning with multiparametric voxel-based morphometry methods.
J Neurooncol. 2022 Sep 5. pii: 10.1007/s11060-022-04127.
PubMed Abstract available

SHIDOH S, Savjani RR, Cho NS, Ullman HE, et al
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation.
J Neurooncol. 2022 Sep 2. pii: 10.1007/s11060-022-04123.
PubMed Abstract available

TAKAMI H, Graffeo CS, Perry A, Brown DA, et al
Presentation, imaging, patterns of care, growth, and outcome in sporadic and von Hippel-Lindau-associated central nervous system hemangioblastomas.
J Neurooncol. 2022;159:221-231.
PubMed Abstract available

SHIBAHARA I, Shibahara Y, Hagiwara H, Watanabe T, et al
Ventricular opening and cerebrospinal fluid circulation accelerate the biodegradation process of carmustine wafers suggesting their immunomodulation potential in the human brain.
J Neurooncol. 2022;159:425-435.
PubMed Abstract available

GELHARD S, Maxwell A, Colman H, Cohen AL, et al
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis.
J Neurooncol. 2022;159:293-300.
PubMed Abstract available

ALIOUAT I, Moiraghi A, Simboli GA, Birsen R, et al
Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience.
J Neurooncol. 2022;159:347-358.
PubMed Abstract available

GARZIO K, McElroy K, Grossman S, Holdhoff M, et al
Safety of temozolomide use in adult patients with renal dysfunction.
J Neurooncol. 2022;159:591-596.
PubMed Abstract available

KALAWI AZ, Malicki DM, Abdullaev Z, Pratt DW, et al
The role of methylation profiling in histologically diagnosed neurocytoma: a case series.
J Neurooncol. 2022;159:725-733.
PubMed Abstract available

PLANT-FOX AS, Suzuki T, Diaz Coronado RY, Epelman S, et al
An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry.
J Neurooncol. 2022;159:563-570.
PubMed Abstract available

August 2022

KUMAR TS, Afnan WM, Chan CY, Audrey C, et al
Impact of seizures and antiseizure medication on survival in patients with glioma.
J Neurooncol. 2022 Aug 29. pii: 10.1007/s11060-022-04108.
PubMed Abstract available

SAGBERG LM, Fyllingen EH, Hansen TI, Strand PS, et al
Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case-control study.
J Neurooncol. 2022 Aug 27. pii: 10.1007/s11060-022-04120.
PubMed Abstract available

YAN M, Holden L, Wang M, Soliman H, et al
Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume.
J Neurooncol. 2022 Aug 24. pii: 10.1007/s11060-022-04115.
PubMed Abstract available

IMBER BS, Young RJ, Beal K, Reiner AS, et al
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
J Neurooncol. 2022 Aug 23. pii: 10.1007/s11060-022-04121.
PubMed

WANG M, Zhang Y, Shi W, Zhu R, et al
Frameless robot-assisted stereotactic biopsy: an effective and minimally invasive technique for pediatric diffuse intrinsic pontine gliomas.
J Neurooncol. 2022 Aug 23. pii: 10.1007/s11060-022-04122.
PubMed Abstract available

GUNJUR A, Balasubramanian A, Hafeez U, Menon S, et al
Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.
J Neurooncol. 2022 Aug 22. pii: 10.1007/s11060-022-04119.
PubMed

KIM M, Kim S, Park YW, Han K, et al
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification.
J Neurooncol. 2022 Aug 21. pii: 10.1007/s11060-022-04114.
PubMed Abstract available

PARTIN RE, Wogksch MD, Dhaduk R, Ashford JM, et al
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up.
J Neurooncol. 2022 Aug 20. pii: 10.1007/s11060-022-04116.
PubMed Abstract available

SIMOES PADILLA C, Ho VKY, van der Strate IH, Leenders WPJ, et al
Prognostic factors among patients with brain metastases from cancer of unknown primary site.
J Neurooncol. 2022 Aug 17. pii: 10.1007/s11060-022-04106.
PubMed Abstract available

MA J, Tian Y, Hao S, Zheng L, et al
Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis.
J Neurooncol. 2022 Aug 17. pii: 10.1007/s11060-022-04111.
PubMed Abstract available

BIN-ALAMER O, Alnefaie N, Qedair J, Chaudhary A, et al
Single session versus multisession stereotactic radiosurgery for the management of intracranial meningiomas: a systematic review and meta-analysis.
J Neurooncol. 2022 Aug 17. pii: 10.1007/s11060-022-04112.
PubMed Abstract available

LIAO HR, Chiang CL, Shen CI, Chen CJ, et al
EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.
J Neurooncol. 2022 Aug 17. pii: 10.1007/s11060-022-04110.
PubMed Abstract available

LI S, Wu B, Xiao Y, Wu J, et al
Exploring the pathological relationships between adamantinomatous craniopharyngioma and contiguous structures with tumor origin.
J Neurooncol. 2022 Aug 8. pii: 10.1007/s11060-022-04084.
PubMed Abstract available

HOLLINGWORTH M, Zacharoulis S
Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma.
J Neurooncol. 2022 Aug 6. pii: 10.1007/s11060-022-04077.
PubMed Abstract available

GUNJUR A, Balasubramanian A, Hafeez U, Menon S, et al
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.
J Neurooncol. 2022 Aug 6. pii: 10.1007/s11060-022-04092.
PubMed Abstract available

CLIMANS SA, Mason WP, Grunfeld E, Chan K, et al
Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy.
J Neurooncol. 2022 Aug 6. pii: 10.1007/s11060-022-04109.
PubMed Abstract available

PONTORIERO A, Critelli P, Conti A, Cardali S, et al
The "Combo" radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis.
J Neurooncol. 2022 Aug 4. pii: 10.1007/s11060-022-04107.
PubMed Abstract available

LOHKAMP LN, Kulkarni AV, Drake JM, Rutka JT, et al
Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma.
J Neurooncol. 2022 Aug 4. pii: 10.1007/s11060-022-04099.
PubMed Abstract available

ONISHI S, Yamasaki F, Amatya VJ, Takayasu T, et al
Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review.
J Neurooncol. 2022 Aug 3. pii: 10.1007/s11060-022-04090.
PubMed Abstract available

TANG AR, Chotai S, Grisham CJ, Guidry BS, et al
Outcomes following surgical resection of cystic intracranial meningiomas.
J Neurooncol. 2022 Aug 3. pii: 10.1007/s11060-022-04096.
PubMed Abstract available

VUONG HG, Dunn IF
Primary versus secondary gliosarcoma: a systematic review and meta-analysis.
J Neurooncol. 2022;159:195-200.
PubMed Abstract available

DESJARDINS C, Larrieu-Ciron D, Choquet S, Mokhtari K, et al
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.
J Neurooncol. 2022;159:151-161.
PubMed Abstract available

ID SAID B, Chen H, Jerzak KJ, Warner E, et al
Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer.
J Neurooncol. 2022;159:177-183.
PubMed Abstract available

RAKOVEC M, Khalafallah AM, Wei O, Day D, et al
A consensus definition of supratotal resection for anatomically distinct primary glioblastoma: an AANS/CNS Section on Tumors survey of neurosurgical oncologists.
J Neurooncol. 2022 Aug 1. pii: 10.1007/s11060-022-04048.
PubMed Abstract available

July 2022

IMBER BS, Young RJ, Beal K, Reiner AS, et al
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
J Neurooncol. 2022 Jul 27. pii: 10.1007/s11060-022-04101.
PubMed Abstract available

DAZA-OVALLE A, Bin-Alamer O, Flickinger J, Niranjan A, et al
Outcomes after gamma knife radiosurgery for intraventricular meningiomas.
J Neurooncol. 2022 Jul 26. pii: 10.1007/s11060-022-04091.
PubMed Abstract available

DO TH, Howard MA, Palzer EF, Huling JD, et al
Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Readmissions Database (NRD).
J Neurooncol. 2022 Jul 23. pii: 10.1007/s11060-022-04093.
PubMed Abstract available

LUGER AL, Konig S, Samp PF, Urban H, et al
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
J Neurooncol. 2022 Jul 21. pii: 10.1007/s11060-022-04049.
PubMed Abstract available

YOGENDRAN LV, Kalelioglu T, Donahue JH, Ahmad H, et al
The landscape of brain tumor mimics in neuro-oncology practice.
J Neurooncol. 2022 Jul 20. pii: 10.1007/s11060-022-04087.
PubMed Abstract available

MENDEZ VALDEZ MJ, Lu VM, Kim E, Rivas SR, et al
Glioblastoma multiforme in patients with human immunodeficiency virus: an integrated review and analysis.
J Neurooncol. 2022 Jul 20. pii: 10.1007/s11060-022-04095.
PubMed Abstract available

MOASSEFI M, Faghani S, Conte GM, Kowalchuk RO, et al
A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients.
J Neurooncol. 2022 Jul 19. pii: 10.1007/s11060-022-04080.
PubMed Abstract available

MULLER M, Winz O, Gutsche R, Leijenaar RTH, et al
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.
J Neurooncol. 2022 Jul 19. pii: 10.1007/s11060-022-04089.
PubMed Abstract available

HAGIWARA A, Schlossman J, Shabani S, Raymond C, et al
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
J Neurooncol. 2022 Jul 17. pii: 10.1007/s11060-022-04088.
PubMed Abstract available

MELNICK KF, Miller P, Carmichael E, McGrath K, et al
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival.
J Neurooncol. 2022 Jul 15. pii: 10.1007/s11060-022-04083.
PubMed Abstract available

DE BRITO RANGEL J, Giglio AG, Cardozo CL, Bergmann A, et al
Prognostic factors for brain metastasis in women presenting cervical cancer.
J Neurooncol. 2022 Jul 14. pii: 10.1007/s11060-022-04082.
PubMed Abstract available

RECKER MJ, Kuo CC, Prasad D, Attwood K, et al
Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018.
J Neurooncol. 2022 Jul 11. pii: 10.1007/s11060-022-04085.
PubMed Abstract available

FUJITA Y, Nunez-Rubiano L, Dono A, Bellman A, et al
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.
J Neurooncol. 2022 Jul 11. pii: 10.1007/s11060-022-04060.
PubMed Abstract available

KAWASHIMA M, Akabane A, Noda R, Segawa M, et al
Interfractional change of tumor volume during fractionated stereotactic radiotherapy using gamma knife for brain metastases.
J Neurooncol. 2022 Jul 9. pii: 10.1007/s11060-022-04075.
PubMed Abstract available

MASSIMINO M, Vennarini S, Barretta F, Colombo F, et al
How ten-years of reirradiation for paediatric high-grade glioma may shed light on first line treatment.
J Neurooncol. 2022 Jul 9. pii: 10.1007/s11060-022-04079.
PubMed Abstract available

SCHLOMER S, Felsberg J, Pertz M, Hentschel B, et al
Mid-term treatment-related cognitive sequelae in glioma patients.
J Neurooncol. 2022 Jul 7. pii: 10.1007/s11060-022-04044.
PubMed Abstract available

PEI YY, Zhang Y, Liu ZR, He Y, et al
Lactate dehydrogenase as promising marker for prognosis of brain metastasis.
J Neurooncol. 2022 Jul 7. pii: 10.1007/s11060-022-04070.
PubMed Abstract available

TOBOCHNIK S, Lapinskas E, Vogelzang J, Ligon KL, et al
Correction to: Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma.
J Neurooncol. 2022 Jul 6. pii: 10.1007/s11060-022-04086.
PubMed

BUNEVICIUS A, Donovan L, Sheehan J
Health related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review.
J Neurooncol. 2022 Jul 4. pii: 10.1007/s11060-022-04067.
PubMed Abstract available

SUZUKI H, Ono T, Koyota S, Takahashi M, et al
Clinical, histopathological, and molecular features of IDH-wildtype indolent diffuse glioma: comparison with typical glioblastoma.
J Neurooncol. 2022 Jul 2. pii: 10.1007/s11060-022-04074.
PubMed Abstract available

MALDAR AN, Pattankar S, Misra BK, Chauhan PH, et al
Long-term hormonal and imaging outcomes of adjunctive gamma knife radiosurgery in non-functioning pituitary adenomas: a single center experience.
J Neurooncol. 2022;158:423-433.
PubMed Abstract available

BANDER ED, Knisely JPS, Schwartz TH
Brachytherapy for central nervous system tumors.
J Neurooncol. 2022;158:393-403.
PubMed Abstract available

June 2022

DE LAURENTIS C, Cristaldi PMF, Rebora P, Valsecchi MG, et al
Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous and consecutive series of 136 patients.
J Neurooncol. 2022 Jun 29. pii: 10.1007/s11060-022-04072.
PubMed Abstract available

WANG F, Cathcart SJ, DiMaio DJ, Zhao N, et al
Comparison of tumor immune environment between newly diagnosed and recurrent glioblastoma including matched patients.
J Neurooncol. 2022 Jun 26. pii: 10.1007/s11060-022-04053.
PubMed Abstract available

PALMER JD, Perlow HK, Matsui JK, Ho C, et al
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
J Neurooncol. 2022 Jun 25. pii: 10.1007/s11060-022-04073.
PubMed Abstract available

GREER HR, Miller K, Samay S, Nellan A, et al
Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis.
J Neurooncol. 2022 Jun 22. pii: 10.1007/s11060-022-04065.
PubMed Abstract available

PETERSON R, Kandregula S, Jee E, Guthikonda B, et al
Utility of hospital frailty risk score for predicting postoperative outcomes in craniopharyngioma.
J Neurooncol. 2022 Jun 20. pii: 10.1007/s11060-022-04056.
PubMed Abstract available

WIJAYA JH, Arjuna YYE, July J
The role of stereotactic radiosurgery in the management of petroclival meningioma: a systematic review.
J Neurooncol. 2022 Jun 18. pii: 10.1007/s11060-022-04041.
PubMed Abstract available

BRACCI PM, Rice T, Hansen HM, Francis SS, et al
Pre-surgery immune profiles of adult glioma patients.
J Neurooncol. 2022 Jun 18. pii: 10.1007/s11060-022-04047.
PubMed Abstract available

WERNER JM, Wolf L, Tscherpel C, Bauer EK, et al
Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas.
J Neurooncol. 2022 Jun 18. pii: 10.1007/s11060-022-04066.
PubMed Abstract available

SPECKTER H, Radulovic M, Trivodaliev K, Vranes V, et al
MRI radiomics in the prediction of the volumetric response in meningiomas after gamma knife radiosurgery.
J Neurooncol. 2022 Jun 17. pii: 10.1007/s11060-022-04063.
PubMed Abstract available

TOBOCHNIK S, Lapinskas E, Vogelzang J, Ligon KL, et al
Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma.
J Neurooncol. 2022 Jun 17. pii: 10.1007/s11060-022-04059.
PubMed Abstract available

PRADHAN A, Mozaffari K, Ghodrati F, Everson RG, et al
Modern surgical management of incidental gliomas.
J Neurooncol. 2022 Jun 15. pii: 10.1007/s11060-022-04045.
PubMed Abstract available

WELLER J, Schafer N, Schaub C, Potthoff AL, et al
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
J Neurooncol. 2022 Jun 15. pii: 10.1007/s11060-022-04046.
PubMed Abstract available

RAMOS-FRESNEDO A, Domingo RA, Perez-Vega C, Pullen MW, et al
The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.
J Neurooncol. 2022 Jun 14. pii: 10.1007/s11060-022-04040.
PubMed Abstract available

PALMISCIANO P, Haider AS, Balasubramanian K, D'Amico RS, et al
The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.
J Neurooncol. 2022 Jun 13. pii: 10.1007/s11060-022-04050.
PubMed Abstract available

AUTRY AW, Lafontaine M, Jalbert L, Phillips E, et al
Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas.
J Neurooncol. 2022 Jun 8. pii: 10.1007/s11060-022-04042.
PubMed Abstract available

MICHEL A, Dinger TF, Santos AN, Pierscianek D, et al
Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.
J Neurooncol. 2022 Jun 7. pii: 10.1007/s11060-022-04043.
PubMed Abstract available

AMER RG, Ezz El Arab LR, Abd El Ghany D, Saad AS, et al
Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM).
J Neurooncol. 2022 Jun 6. pii: 10.1007/s11060-022-04030.
PubMed Abstract available

BERGER A, Bernstein K, Alzate JD, Mullen R, et al
Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?
J Neurooncol. 2022 Jun 4. pii: 10.1007/s11060-022-04036.
PubMed Abstract available

CHEN ZH, Zhang XH, Lin FH, Li C, et al
The application of fluorescein sodium for the resection of medulloblastoma.
J Neurooncol. 2022 Jun 3. pii: 10.1007/s11060-022-04035.
PubMed Abstract available

SHAH HA, Mishra A, Gouzoulis MJ, Ben-Shalom N, et al
Analysis of factors leading to early termination in glioblastoma-related clinical trials.
J Neurooncol. 2022 Jun 1. pii: 10.1007/s11060-022-04039.
PubMed Abstract available

GOODMAN AL, Velazquez Vega JE, Glenn C, Olson JJ, et al
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.
J Neurooncol. 2022 Jun 1. pii: 10.1007/s11060-022-04005.
PubMed Abstract available

May 2022

LE A, Mohammadi H, Mohammed T, Burney H, et al
Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition.
J Neurooncol. 2022 May 31. pii: 10.1007/s11060-022-04038.
PubMed Abstract available

OBERHEIM-BUSH NA, Shi W, McDermott MW, Grote A, et al
The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts.
J Neurooncol. 2022 May 31. pii: 10.1007/s11060-022-04033.
PubMed Abstract available

PEREIRA ELR, Feio DCA, Tavares JPL, Morikawa NM, et al
Uptake of lipid core nanoparticles by fragments of tissues collected during cerebral tumor excision surgeries: hypotheses for use in drug targeting therapy.
J Neurooncol. 2022 May 25. pii: 10.1007/s11060-022-04028.
PubMed Abstract available

REN L, Hua L, Bao Z, Deng J, et al
Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.
J Neurooncol. 2022 May 25. pii: 10.1007/s11060-022-04034.
PubMed Abstract available

VUONG HG, Ngo TNM, Le HT, Dunn IF, et al
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age.
J Neurooncol. 2022 May 23. pii: 10.1007/s11060-022-04027.
PubMed Abstract available

DADEY DYA, Rodrigues A, Haider G, Pollom EL, et al
Impact of socio-economic factors on radiation treatment after resection of metastatic brain tumors: trends from a private insurance database.
J Neurooncol. 2022 May 21. pii: 10.1007/s11060-022-04031.
PubMed Abstract available

BREEN WG, Youland RS, Giri S, Jacobson SB, et al
Initial results of a phase II trial of (18)F-DOPA PET-guided re-irradiation for recurrent high-grade glioma.
J Neurooncol. 2022 May 18. pii: 10.1007/s11060-022-04011.
PubMed Abstract available

STRONG MJ, Koduri S, Allison JA, Pesavento CM, et al
Bone metastasis from glioblastoma: a systematic review.
J Neurooncol. 2022 May 17. pii: 10.1007/s11060-022-04025.
PubMed Abstract available

LOPEZ-PEREZ CA, Franco-Mojica X, Villanueva-Gaona R, Diaz-Alba A, et al
Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity.
J Neurooncol. 2022 May 14. pii: 10.1007/s11060-022-04024.
PubMed Abstract available

RAMMOHAN N, Ho A, Saxena M, Bajaj A, et al
Tumor-associated alterations in white matter connectivity have prognostic significance in MGMT-unmethylated glioblastoma.
J Neurooncol. 2022 May 7. pii: 10.1007/s11060-022-04018.
PubMed Abstract available

SHAO N, Mao J, Xue L, Wang R, et al
Correction to: Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.
J Neurooncol. 2022 May 4. pii: 10.1007/s11060-022-04006.
PubMed

RIVERA PERLA KM, Tang OY, Durfey SNM, Vivas-Buitrago T, et al
Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI).
J Neurooncol. 2022 May 3. pii: 10.1007/s11060-022-04020.
PubMed Abstract available

MCTHENIA SS, Pandit-Taskar N, Grkovski M, Donzelli MA, et al
Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device.
J Neurooncol. 2022;157:457-463.
PubMed Abstract available

LIU KX, Shang HH, Cacciotti C, Everdell E, et al
DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
J Neurooncol. 2022;157:499-510.
PubMed Abstract available

WICKENHAUSER ME, Khan RB, Raches D, Ashford JM, et al
The posterior fossa syndrome questionnaire: using science to inform practice.
J Neurooncol. 2022;157:465-473.
PubMed Abstract available

LIU ZM, Han Z, Wang JM, Sun T, et al
Treatment and outcome of pediatric intracranial ependymoma after first relapse.
J Neurooncol. 2022;157:385-396.
PubMed Abstract available

HERSH AM, Antar A, Pennington Z, Aygun N, et al
Predictors of survival and time to progression following operative management of intramedullary spinal cord astrocytomas.
J Neurooncol. 2022;158:117-127.
PubMed Abstract available

KAVOURIDIS VK, Ligon KL, Wen PY, Iorgulescu JB, et al
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients.
J Neurooncol. 2022;158:111-116.
PubMed Abstract available

IRONSIDE N, Snyder H, Xu Z, Schlesinger D, et al
Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
J Neurooncol. 2022;158:41-50.
PubMed Abstract available

DEATKINE AB, Abdelrashid M, Tucker Z, Mehta A, et al
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors.
J Neurooncol. 2022;158:33-40.
PubMed Abstract available

April 2022

PARK DY, Tom MC, Chen Y, Tewari S, et al
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas.
J Neurooncol. 2022 Apr 29. pii: 10.1007/s11060-022-04019.
PubMed Abstract available

ZEITLBERGER AM, Putora PM, Hofer S, Schucht P, et al
Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.
J Neurooncol. 2022 Apr 29. pii: 10.1007/s11060-022-04022.
PubMed Abstract available

CHANG L, Wang J, Zhou F, Wang D, et al
Retraction Note to: LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
J Neurooncol. 2022 Apr 28. pii: 10.1007/s11060-022-04023.
PubMed

KLINGENSCHMID J, Krigers A, Pinggera D, Kerschbaumer J, et al
The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma.
J Neurooncol. 2022 Apr 25. pii: 10.1007/s11060-022-04001.
PubMed Abstract available

NEMATI H, Fakhre-Taha M, Javanmard AR, Jahanbakhshi A, et al
LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma.
J Neurooncol. 2022 Apr 23. pii: 10.1007/s11060-022-03992.
PubMed Abstract available

WALSH LE, Polacek LC, Panageas K, Reiner A, et al
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists.
J Neurooncol. 2022 Apr 18. pii: 10.1007/s11060-022-04010.
PubMed Abstract available

LOUGHAN AR, Willis KD, Braun SE, Rodin G, et al
Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial.
J Neurooncol. 2022 Apr 18. pii: 10.1007/s11060-022-03988.
PubMed Abstract available

AOYAMA M, Masukawa K, Sugiyama I, Morita T, et al
Comparison of the quality of death between primary malignant brain tumor patients and other cancer patients: results from a nationwide bereavement survey in Japan.
J Neurooncol. 2022 Apr 18. pii: 10.1007/s11060-022-04013.
PubMed Abstract available

CAI Q, Wu Y, Wang S, Huang T, et al
Preoperative antiepileptic drug prophylaxis for early postoperative seizures in supratentorial meningioma: a single-center experience.
J Neurooncol. 2022 Apr 17. pii: 10.1007/s11060-022-04009.
PubMed Abstract available

SINGH DK, Shivalingappa PKM, Sharma A, Mondal A, et al
NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
J Neurooncol. 2022 Apr 17. pii: 10.1007/s11060-022-04002.
PubMed Abstract available

KERSCHBAUMER J, Krigers A, Demetz M, Pinggera D, et al
The Clinical Frailty Scale as useful tool in patients with brain metastases.
J Neurooncol. 2022 Apr 13. pii: 10.1007/s11060-022-04008.
PubMed Abstract available

HOSOYA T, Takahashi M, Honda-Kitahara M, Miyakita Y, et al
MGMT gene promoter methylation by pyrosequencing method correlates volumetric response and neurological status in IDH wild-type glioblastomas.
J Neurooncol. 2022 Apr 10. pii: 10.1007/s11060-022-03999.
PubMed Abstract available

HALKETT GKB, Berg MN, Daudu D, Dhillon HM, et al
Supportive care of patients diagnosed with high grade glioma and their carers in Australia.
J Neurooncol. 2022 Apr 9. pii: 10.1007/s11060-022-03991.
PubMed Abstract available

MO F, Meletti S, Belcastro V, Quadri S, et al
Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
J Neurooncol. 2022 Apr 9. pii: 10.1007/s11060-022-03998.
PubMed Abstract available

LOUGHAN AR, Reid M, Willis KD, Davies A, et al
The burden of a brain tumor: guiding patient centric care in neuro-oncology.
J Neurooncol. 2022 Apr 8. pii: 10.1007/s11060-022-03993.
PubMed Abstract available

STOYANOV GS, Lyutfi E, Georgieva R, Georgiev R, et al
Diaph3 underlines tumor cell heterogeneity in glioblastoma with implications for treatment modalities resistance.
J Neurooncol. 2022 Apr 5. pii: 10.1007/s11060-022-03996.
PubMed Abstract available

STOYANOV GS
Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study".
J Neurooncol. 2022 Apr 5. pii: 10.1007/s11060-022-04000.
PubMed

MARCHETTI M, Pinzi V, Iezzoni C, Morlino S, et al
Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial.
J Neurooncol. 2022 Apr 4. pii: 10.1007/s11060-022-03978.
PubMed Abstract available

MESNY E, Barritault M, Izquierdo C, Poncet D, et al
Gyriform infiltration as imaging biomarker for molecular glioblastomas.
J Neurooncol. 2022 Apr 1. pii: 10.1007/s11060-022-03995.
PubMed Abstract available

GIANTINI-LARSEN AM, Garton ALA, Villamater FN, Kuzan-Fischer CM, et al
Familial colloid cysts: not a chance occurrence.
J Neurooncol. 2022;157:321-332.
PubMed Abstract available

KIM C, Lim M, Woodworth GF, Arvanitis CD, et al
The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.
J Neurooncol. 2022;157:221-236.
PubMed Abstract available

HART M, Anderson-Mellies A, Beltrami A, Gilani A, et al
Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups.
J Neurooncol. 2022;157:333-344.
PubMed Abstract available

METZGER S, Weiser A, Gerber NU, Otth M, et al
Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes.
J Neurooncol. 2022;157:307-317.
PubMed Abstract available

March 2022

BERTHOLD D, Carrasco AP, Uhl E, Muller H, et al
Palliative care of older glioblastoma patients in neurosurgery.
J Neurooncol. 2022 Mar 24. pii: 10.1007/s11060-022-03985.
PubMed Abstract available

WEI Z, Niranjan A, Abou-Al-Shaar H, Deng H, et al
A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases.
J Neurooncol. 2022 Mar 22. pii: 10.1007/s11060-022-03981.
PubMed Abstract available

GRITSCH D, Castro LNG
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review.
J Neurooncol. 2022 Mar 21. pii: 10.1007/s11060-022-03984.
PubMed Abstract available

NIDAMANURI P, Drappatz J
Immune checkpoint inhibitor therapy for recurrent meningiomas: a retrospective chart review.
J Neurooncol. 2022 Mar 17. pii: 10.1007/s11060-022-03979.
PubMed Abstract available

BIN ALAMER O, Palmisciano P, Mallela AN, Labib MA, et al
Stereotactic radiosurgery in the management of petroclival meningiomas: a systematic review and meta-analysis of treatment outcomes of primary and adjuvant radiosurgery.
J Neurooncol. 2022 Mar 17. pii: 10.1007/s11060-021-03934.
PubMed Abstract available

RUTENBERG MS, Holtzman AL, Indelicato DJ, Huh S, et al
Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series.
J Neurooncol. 2022 Mar 12. pii: 10.1007/s11060-022-03983.
PubMed Abstract available

VANHAUWAERT D, Pinson H, Sweldens C, Du Four S, et al
Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey.
J Neurooncol. 2022 Mar 11. pii: 10.1007/s11060-022-03971.
PubMed Abstract available

MOON HH, Park JE, Kim YH, Kim JH, et al
Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment.
J Neurooncol. 2022 Mar 11. pii: 10.1007/s11060-022-03980.
PubMed Abstract available

ROBERTS JW, Powlovich L, Sheybani N, LeBlang S, et al
Focused ultrasound for the treatment of glioblastoma.
J Neurooncol. 2022 Mar 10. pii: 10.1007/s11060-022-03974.
PubMed Abstract available

BARRAGAN-PEREZ EJ, Alvarez-Amado DE, Dies-Suarez P, Tobon SH, et al
Compassionate use of Quantum Magnetic Resonance Therapy for treatment of children with Diffuse Brainstem Glioma in Mexico City: a single institutional experience.
J Neurooncol. 2022 Mar 10. pii: 10.1007/s11060-022-03972.
PubMed Abstract available

MILLS MN, King W, Soyano A, Pina Y, et al
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
J Neurooncol. 2022 Mar 4. pii: 10.1007/s11060-022-03977.
PubMed Abstract available

PATRICK HH, Sherman JH, Elder JB, Olson JJ, et al
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults.
J Neurooncol. 2022 Mar 4. pii: 10.1007/s11060-021-03881.
PubMed Abstract available

DE MARCELLUS C, Tauziede-Espariat A, Cuinet A, Pasqualini C, et al
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients.
J Neurooncol. 2022 Mar 3. pii: 10.1007/s11060-022-03970.
PubMed Abstract available

BROGGI G, Gianno F, Shemy DT, Massimino M, et al
Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases.
J Neurooncol. 2022;157:1-14.
PubMed Abstract available

DIAZ M, Singh P, Kotchetkov IS, Skakodub A, et al
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
J Neurooncol. 2022;157:81-90.
PubMed Abstract available

PECIU-FLORIANU I, Legrand V, Monfilliette-Djelad A, Maurage CA, et al
Frameless robot-assisted stereotactic biopsies for lesions of the brainstem-a series of 103 consecutive biopsies.
J Neurooncol. 2022;157:109-119.
PubMed Abstract available

February 2022

GROGAN D, Bray DP, Cosgrove M, Boucher A, et al
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review.
J Neurooncol. 2022 Feb 25. pii: 10.1007/s11060-022-03961.
PubMed Abstract available

BYRNE E, Abel S, Yu A, Shepard M, et al
Trends in radiation dose for low grade gliomas across the United States.
J Neurooncol. 2022 Feb 23. pii: 10.1007/s11060-022-03962.
PubMed Abstract available

GERMANO IM, Ziu M, Wen P, Ormond DR, et al
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.
J Neurooncol. 2022 Feb 23. pii: 10.1007/s11060-021-03900.
PubMed Abstract available

VALLEJO FA, Eichberg DG, Morell AA, Shah AH, et al
Same-day discharge after brain tumor resection: a prospective pilot study.
J Neurooncol. 2022 Feb 22. pii: 10.1007/s11060-022-03969.
PubMed Abstract available

OBRECHT D, Mynarek M, Hagel C, Kwiecien R, et al
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.
J Neurooncol. 2022 Feb 21. pii: 10.1007/s11060-021-03913.
PubMed Abstract available

LIN R, Xu Y, Xie S, Zhang Y, et al
Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma.
J Neurooncol. 2022 Feb 21. pii: 10.1007/s11060-022-03964.
PubMed Abstract available

RAMOS-FRESNEDO A, Pullen MW, Perez-Vega C, Domingo RA, et al
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study.
J Neurooncol. 2022 Feb 17. pii: 10.1007/s11060-022-03960.
PubMed Abstract available

MORENO DA, da Silva LS, Zanon MF, Bonatelli M, et al
Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study.
J Neurooncol. 2022 Feb 15. pii: 10.1007/s11060-022-03965.
PubMed Abstract available

ABDULHALEEM M, Johnston H, D'Agostino R Jr, Lanier C, et al
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases.
J Neurooncol. 2022 Feb 15. pii: 10.1007/s11060-022-03951.
PubMed Abstract available

SOLANO-PAEZ P, Fonseca A, Baroni LV, Amayiri N, et al
Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites.
J Neurooncol. 2022 Feb 5. pii: 10.1007/s11060-022-03956.
PubMed Abstract available

HAIM O, Abramov S, Shofty B, Fanizzi C, et al
Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases.
J Neurooncol. 2022 Feb 4. pii: 10.1007/s11060-022-03946.
PubMed Abstract available

FATIMA N, Maxwell AK, La Dine A, Barnard ZR, et al
Predictors of hearing functional outcome following surgery for cerebellopontine angle meningioma.
J Neurooncol. 2022 Feb 3. pii: 10.1007/s11060-022-03958.
PubMed Abstract available

HAQUE W, Teh C, Butler EB, Teh BS, et al
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma.
J Neurooncol. 2022 Feb 1. pii: 10.1007/s11060-022-03955.
PubMed Abstract available

SHEPARD MJ, Haider AS, Prabhu SS, Sawaya R, et al
Long term outcomes following surgery for pineal region tumors.
J Neurooncol. 2022;156:491-498.
PubMed Abstract available

LUKAS RV, Thakkar JP, Cristofanilli M, Chandra S, et al
Leptomeningeal metastases: the future is now.
J Neurooncol. 2022;156:443-452.
PubMed Abstract available

WOLFF JE, Van Gool SW, Kutluk T, Diez B, et al
Final results of the Choroid Plexus Tumor study CPT-SIOP-2000.
J Neurooncol. 2022;156:599-613.
PubMed Abstract available

January 2022

LEE YP, Jung HA, Lee MS, Choi JW, et al
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
J Neurooncol. 2022 Jan 30. pii: 10.1007/s11060-021-03930.
PubMed Abstract available

YANG K, Landry AP, Aljoghaiman M, Gutierrez E, et al
Postoperative CT scans after resection of brain metastases: neurosurgical routine or added value?
J Neurooncol. 2022 Jan 29. pii: 10.1007/s11060-022-03957.
PubMed Abstract available

CHIANG JA, Feghali PT, Saavedra A, Whitaker AM, et al
Effects of sleep disturbance on neuropsychological functioning in patients with pediatric brain tumor.
J Neurooncol. 2022 Jan 29. pii: 10.1007/s11060-022-03954.
PubMed Abstract available

PIKIS S, Mantziaris G, Islim AI, Peker S, et al
Stereotactic radiosurgery versus active surveillance for incidental, convexity meningiomas: a matched cohort analysis from the IMPASSE study.
J Neurooncol. 2022 Jan 29. pii: 10.1007/s11060-022-03953.
PubMed Abstract available

MARKU M, Rasmussen BK, Belmonte F, Andersen EAW, et al
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018.
J Neurooncol. 2022 Jan 28. pii: 10.1007/s11060-022-03948.
PubMed Abstract available

NETH BJ, Balakrishnan SN, Carabenciov ID, Uhm JH, et al
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience.
J Neurooncol. 2022 Jan 25. pii: 10.1007/s11060-022-03950.
PubMed Abstract available

GERRITSEN JKW, Broekman MLD, De Vleeschouwer S, Schucht P, et al
Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey.
J Neurooncol. 2022 Jan 24. pii: 10.1007/s11060-021-03894.
PubMed Abstract available

MANTZIARIS G, Pikis S, Samanci Y, Peker S, et al
Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study.
J Neurooncol. 2022 Jan 24. pii: 10.1007/s11060-021-03923.
PubMed Abstract available

NORONHA C, Ribeiro AS, Taipa R, Leitao D, et al
PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma.
J Neurooncol. 2022 Jan 23. pii: 10.1007/s11060-021-03907.
PubMed Abstract available

PARK DY, Tom MC, Wei W, Tewari S, et al
Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma.
J Neurooncol. 2022 Jan 22. pii: 10.1007/s11060-021-03920.
PubMed Abstract available

NAZEM A, Guiry SC, Pourfathi M, Ware JB, et al
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma.
J Neurooncol. 2022 Jan 19. pii: 10.1007/s11060-022-03947.
PubMed Abstract available

MOITRA P, Chatterjee A, Kota PK, Epari S, et al
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study.
J Neurooncol. 2022 Jan 17. pii: 10.1007/s11060-022-03944.
PubMed Abstract available

LAMBA N, Groves A, Torre M, Yeo KK, et al
The epidemiology of primary and metastatic brain tumors in infancy through childhood.
J Neurooncol. 2022 Jan 17. pii: 10.1007/s11060-021-03927.
PubMed Abstract available

DADARIO NB, Zaman A, Pandya M, Dlouhy BJ, et al
Endoscopic-assisted surgical approach for butterfly glioma surgery.
J Neurooncol. 2022 Jan 15. pii: 10.1007/s11060-022-03945.
PubMed Abstract available

TANG OY, Clarke RA, Rivera Perla KM, Corcoran Ruiz KM, et al
Brain tumor craniotomy outcomes for dual-eligible medicare and medicaid patients: a 10-year nationwide analysis.
J Neurooncol. 2022 Jan 13. pii: 10.1007/s11060-021-03922.
PubMed Abstract available

AFTAB K, Aamir FB, Mallick S, Mubarak F, et al
Radiomics for precision medicine in glioblastoma.
J Neurooncol. 2022 Jan 12. pii: 10.1007/s11060-021-03933.
PubMed Abstract available

MASSARWEH A, Tschernichovsky R, Stemmer A, Benouaich-Amiel A, et al
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study.
J Neurooncol. 2022 Jan 12. pii: 10.1007/s11060-021-03911.
PubMed Abstract available

PERLOW HK, Yaney A, Yang M, Klamer B, et al
Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma.
J Neurooncol. 2022 Jan 11. pii: 10.1007/s11060-021-03925.
PubMed Abstract available

PENA PINO I, Ma J, Hori YS, Fomchenko E, et al
Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience.
J Neurooncol. 2022 Jan 10. pii: 10.1007/s11060-021-03893.
PubMed Abstract available

DONO A, Zhu P, Holmes E, Takayasu T, et al
Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma.
J Neurooncol. 2022 Jan 8. pii: 10.1007/s11060-021-03917.
PubMed Abstract available

KILIAN A, Aigner A, Simon M, Salchow DJ, et al
Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma - a retrospective Magnetic Resonance Imaging study.
J Neurooncol. 2022 Jan 7. pii: 10.1007/s11060-021-03941.
PubMed Abstract available

GRIMALDI S, Harlay V, Appay R, Bequet C, et al
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients.
J Neurooncol. 2022 Jan 7. pii: 10.1007/s11060-022-03943.
PubMed Abstract available

EATZ TA, Eichberg DG, Lu VM, Di L, et al
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
J Neurooncol. 2022 Jan 6. pii: 10.1007/s11060-021-03901.
PubMed Abstract available

KAWAUCHI D, Ohno M, Honda-Kitahara M, Miyakita Y, et al
The clinical characteristics and outcomes of incidentally discovered glioblastoma.
J Neurooncol. 2022 Jan 5. pii: 10.1007/s11060-021-03931.
PubMed Abstract available

MAGANA SM, Peterson TE, Evans JE, Decker PA, et al
Pediatric brain tumor cell lines exhibit miRNA-depleted, Y RNA-enriched extracellular vesicles.
J Neurooncol. 2022 Jan 5. pii: 10.1007/s11060-021-03914.
PubMed Abstract available

CHEN JS, Clarke R, Haddad AF, Wang EJ, et al
The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis.
J Neurooncol. 2022 Jan 4. pii: 10.1007/s11060-021-03940.
PubMed Abstract available

GERAGHTY BJ, Dasgupta A, Sandhu M, Malik N, et al
Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumes.
J Neurooncol. 2022 Jan 3. pii: 10.1007/s11060-021-03939.
PubMed Abstract available

ZUO J, Liu C, Ni H, Yu Z, et al
WDR34 affects PI3K/Akt and Wnt/beta-catenin pathways to regulates malignant biological behaviors of glioma cells.
J Neurooncol. 2022 Jan 3. pii: 10.1007/s11060-021-03932.
PubMed Abstract available

KIM N, Lim DH, Yoon SE, Kim SJ, et al
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma.
J Neurooncol. 2022;156:307-316.
PubMed Abstract available

LOIZIDOU M, Sefcikova V, Ekert JO, Bone M, et al
Reforming support systems of newly diagnosed brain cancer patients: a systematic review.
J Neurooncol. 2022;156:61-71.
PubMed Abstract available

NAKAJIMA R, Kinoshita M, Okita H, Nakada M, et al
Quality of life following awake surgery depends on ability of executive function, verbal fluency, and movement.
J Neurooncol. 2022;156:173-183.
PubMed Abstract available

December 2021

ROBERT SM, Vetsa S, Nadar A, Vasandani S, et al
Correction to: The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.
J Neurooncol. 2021 Dec 30. pii: 10.1007/s11060-021-03937.
PubMed

KLEMENT RJ, Popp I, Kaul D, Ehret F, et al
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.
J Neurooncol. 2021 Dec 23. pii: 10.1007/s11060-021-03926.
PubMed Abstract available

TESKE N, Karschnia P, Weller J, Siller S, et al
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
J Neurooncol. 2021 Dec 13. pii: 10.1007/s11060-021-03912.
PubMed Abstract available

JIMENEZ AE, Khalafallah AM, Botros D, Horowitz MA, et al
The role of anticoagulation for superior sagittal sinus thrombosis following craniotomy for resection of parasagittal/parafalcine meningiomas.
J Neurooncol. 2021 Dec 2. pii: 10.1007/s11060-021-03916.
PubMed Abstract available

JOHNSON KJ, Wang X, Barnes JM, Delavar A, et al
Residential distance from the reporting hospital and survival among adolescents, and young adults diagnosed with CNS tumors.
J Neurooncol. 2021;155:353-361.
PubMed Abstract available

HAINC N, Alsafwani N, Gao A, O'Halloran PJ, et al
The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery.
J Neurooncol. 2021;155:325-333.
PubMed Abstract available

November 2021

ROBERT SM, Vetsa S, Nadar A, Vasandani S, et al
The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications.
J Neurooncol. 2021 Nov 30. pii: 10.1007/s11060-021-03874.
PubMed Abstract available

YOUNG M, Delaney A, Jurbergs N, Pan H, et al
Radiotherapy alone for pediatric patients with craniopharyngioma.
J Neurooncol. 2021 Nov 30. pii: 10.1007/s11060-021-03908.
PubMed Abstract available

SOLER DC, Kerstetter-Fogle A, McCormick TS, Sloan AE, et al
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.
J Neurooncol. 2021 Nov 26. pii: 10.1007/s11060-021-03902.
PubMed Abstract available

GARCIA CR, Myint ZW, Jayswal R, Wang C, et al
Hematological adverse events in the management of glioblastoma.
J Neurooncol. 2021 Nov 24. pii: 10.1007/s11060-021-03891.
PubMed Abstract available

WEFEL JS, Zhou R, Sulman EP, Boehling NS, et al
Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
J Neurooncol. 2021 Nov 24. pii: 10.1007/s11060-021-03905.
PubMed Abstract available

BARAK T, Vetsa S, Nadar A, Jin L, et al
Correction to: Surgical strategies for older patients with glioblastoma.
J Neurooncol. 2021 Nov 23. pii: 10.1007/s11060-021-03888.
PubMed

ROH TH, Lee JH, Kim SJ, Shim JK, et al
A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres.
J Neurooncol. 2021 Nov 22. pii: 10.1007/s11060-021-03903.
PubMed Abstract available

YUSUF M, Rattani A, Gaskins J, Oliver AL, et al
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy.
J Neurooncol. 2021 Nov 22. pii: 10.1007/s11060-021-03899.
PubMed Abstract available

HENDERSON F JR, Schwartz TH
Update on management of craniopharyngiomas.
J Neurooncol. 2021 Nov 22. pii: 10.1007/s11060-021-03906.
PubMed Abstract available

BEHLING F, Fodi C, Wang S, Hempel JM, et al
Increased proliferation is associated with CNS invasion in meningiomas.
J Neurooncol. 2021 Nov 20. pii: 10.1007/s11060-021-03892.
PubMed Abstract available

PAOLI C, Segard S, Burel-Vandenbos F
Is H3 K27M mutation testing relevant in the diagnostic routine of WHO grade 4 gliomas exclusively located in the corpus callosum in adults?
J Neurooncol. 2021 Nov 20. pii: 10.1007/s11060-021-03884.
PubMed

BUNEVICIUS A, Pikis S, Kondziolka D, Patel DN, et al
Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study.
J Neurooncol. 2021 Nov 19. pii: 10.1007/s11060-021-03883.
PubMed Abstract available

PALMISCIANO P, El Ahmadieh TY, Haider AS, Bin Alamer O, et al
Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes.
J Neurooncol. 2021 Nov 19. pii: 10.1007/s11060-021-03898.
PubMed Abstract available

YANG K, Luan L, Li X, Sun X, et al
ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression.
J Neurooncol. 2021 Nov 19. pii: 10.1007/s11060-021-03896.
PubMed Abstract available

VUONG HG, Le HT, Ngo TNM, Fung KM, et al
H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients.
J Neurooncol. 2021 Nov 18. pii: 10.1007/s11060-021-03890.
PubMed Abstract available

SARAN F, Welsh L, James A, McBain C, et al
Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial.
J Neurooncol. 2021 Nov 17. pii: 10.1007/s11060-021-03877.
PubMed Abstract available

PATIL N, Somasundaram E, Waite KA, Lathia JD, et al
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
J Neurooncol. 2021 Nov 10. pii: 10.1007/s11060-021-03886.
PubMed Abstract available

ZIU M, Goyal S, Olson JJ
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults.
J Neurooncol. 2021 Nov 8. pii: 10.1007/s11060-021-03857.
PubMed Abstract available

SHEYBANI ND, Witter AR, Garrison WJ, Miller GW, et al
Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound.
J Neurooncol. 2021 Nov 3. pii: 10.1007/s11060-021-03887.
PubMed Abstract available

YOULDEN DR, Henshaw C, Gottardo NG, Hassall T, et al
Incidence and survival for childhood central nervous system tumours in Australia, 1983-2016.
J Neurooncol. 2021;155:203-213.
PubMed Abstract available

ADOLPH JE, Fleischhack G, Gaab C, Mikasch R, et al
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.
J Neurooncol. 2021;155:193-202.
PubMed Abstract available

WANG S, Sun MZ, Abecassis IJ, Weil AG, et al
Predictors of mortality and tumor recurrence in desmoplastic infantile ganglioglioma and astrocytoma-and individual participant data meta-analysis (IPDMA).
J Neurooncol. 2021;155:155-163.
PubMed Abstract available

LU VM, Luther EM, Eichberg DG, Morell AA, et al
Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
J Neurooncol. 2021;155:165-172.
PubMed Abstract available

October 2021

KANAZAWA T, Ohara K, Kitamura Y, Nakaya M, et al
Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy.
J Neurooncol. 2021 Oct 31. pii: 10.1007/s11060-021-03855.
PubMed Abstract available

JAMAN E, Zhang X, Sandlesh P, Habib A, et al
History of atopy confers improved outcomes in IDH mutant and wildtype lower grade gliomas.
J Neurooncol. 2021 Oct 29. pii: 10.1007/s11060-021-03854.
PubMed Abstract available

HASEGAWA H, Vakharia K, Link MJ, Stafford SL, et al
The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience.
J Neurooncol. 2021 Oct 27. pii: 10.1007/s11060-021-03882.
PubMed Abstract available

WINOGRAD E, Germano I, Wen P, Olson JJ, et al
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.
J Neurooncol. 2021 Oct 25. pii: 10.1007/s11060-021-03876.
PubMed Abstract available

OLSON JJ
Congress of neurological surgeons systematic review and evidence-based guidelines for the treatment of adults with progressive glioblastoma update: introduction and methods.
J Neurooncol. 2021 Oct 25. pii: 10.1007/s11060-021-03850.
PubMed Abstract available

JOHNSON DR, Glenn CA, Javan R, Olson JJ, et al
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
J Neurooncol. 2021 Oct 25. pii: 10.1007/s11060-021-03853.
PubMed Abstract available

MALIK N, Geraghty B, Dasgupta A, Maralani PJ, et al
MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region.
J Neurooncol. 2021 Oct 25. pii: 10.1007/s11060-021-03866.
PubMed Abstract available

DIXIT KS, Sachdev S, Amidei C, Kumthekar P, et al
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
J Neurooncol. 2021 Oct 24. pii: 10.1007/s11060-021-03875.
PubMed Abstract available

GIRARD A, Le Reste PJ, Metais A, Carsin Nicol B, et al
Combining (18)F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.
J Neurooncol. 2021 Oct 22. pii: 10.1007/s11060-021-03873.
PubMed Abstract available

SAMANIC CM, Teer JK, Thompson ZJ, Creed JH, et al
Mitochondrial DNA sequence variation and risk of meningioma.
J Neurooncol. 2021 Oct 20. pii: 10.1007/s11060-021-03878.
PubMed Abstract available

WILCOX JA, Brown S, Reiner AS, Young RJ, et al
Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation.
J Neurooncol. 2021 Oct 16. pii: 10.1007/s11060-021-03872.
PubMed Abstract available

YERRABOTHALA S, Gourley BL, Ford JC, Ahmed SR, et al
Systemic coagulation is activated in patients with meningioma and glioblastoma.
J Neurooncol. 2021 Oct 15. pii: 10.1007/s11060-021-03865.
PubMed Abstract available

SOHN B, An C, Kim D, Ahn SS, et al
Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.
J Neurooncol. 2021 Oct 14. pii: 10.1007/s11060-021-03870.
PubMed Abstract available

FANG S, Liang Y, Li L, Wang L, et al
Correction to: Tumor location-based classification of surgery-related language impairments in patients with glioma.
J Neurooncol. 2021 Oct 12. pii: 10.1007/s11060-021-03871.
PubMed

BARAK T, Vetsa S, Nadar A, Jin L, et al
Surgical strategies for older patients with glioblastoma.
J Neurooncol. 2021 Oct 9. pii: 10.1007/s11060-021-03862.
PubMed Abstract available

AKMAL S, Ginalis EE, Patel NV, Aiken R, et al
Leptomeningeal disease in glioblastoma: endgame or opportunity?
J Neurooncol. 2021 Oct 8. pii: 10.1007/s11060-021-03864.
PubMed Abstract available

RINCON-TORROELLA J, Khela H, Bettegowda A, Bettegowda C, et al
Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients.
J Neurooncol. 2021 Oct 6. pii: 10.1007/s11060-021-03837.
PubMed Abstract available

PATEL NV, Wong T, Fralin SR, Li M, et al
Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial.
J Neurooncol. 2021 Oct 3. pii: 10.1007/s11060-021-03851.
PubMed Abstract available

ALDRICH KD, Horne VE, Bielamowicz K, Sonabend RY, et al
Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
J Neurooncol. 2021 Oct 1. pii: 10.1007/s11060-021-03847.
PubMed Abstract available

FANG S, Liang Y, Li L, Wang L, et al
Tumor location-based classification of surgery-related language impairments in patients with glioma.
J Neurooncol. 2021 Oct 1. pii: 10.1007/s11060-021-03858.
PubMed Abstract available

ORT J, Hamou HA, Kernbach JM, Hakvoort K, et al
(18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection.
J Neurooncol. 2021 Oct 1. pii: 10.1007/s11060-021-03844.
PubMed Abstract available

CABRAL DE CARVALHO CORREA D, Tesser-Gamba F, Dias Oliveira I, Saba da Silva N, et al
Molecular profiling of pediatric and adolescent ependymomas: identification of genetic variants using a next-generation sequencing panel.
J Neurooncol. 2021;155:13-23.
PubMed Abstract available

BROWNE-FARMER C, Hazrati LN, Mamatjan Y, Zadeh G, et al
Paediatric atypical choroid plexus papilloma: is adjuvant therapy necessary?
J Neurooncol. 2021;155:63-70.
PubMed Abstract available

September 2021

FUJITA Y, Nagashima H, Tanaka K, Hashiguchi M, et al
Hyperintense signal on diffusion-weighted imaging for monitoring the acute response and local recurrence after photodynamic therapy in malignant gliomas.
J Neurooncol. 2021 Sep 22. pii: 10.1007/s11060-021-03845.
PubMed Abstract available

CACHO-DIAZ B, Cuapatencatl LD, Rodriguez JA, Garcilazo-Reyes YJ, et al
Identification of a high-risk group for brain metastases in non-small cell lung cancer patients.
J Neurooncol. 2021 Sep 21. pii: 10.1007/s11060-021-03849.
PubMed Abstract available

ROGERS S, Stauffer A, Lomax N, Alonso S, et al
Five fraction stereotactic radiotherapy after brain metastasectomy: a single-institution experience and literature review.
J Neurooncol. 2021 Sep 21. pii: 10.1007/s11060-021-03840.
PubMed Abstract available

CARDONA AF, Jaramillo-Velasquez D, Ruiz-Patino A, Polo C, et al
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
J Neurooncol. 2021 Sep 9. pii: 10.1007/s11060-021-03834.
PubMed Abstract available

BARONI LV, Freytes C, Fernandez Ponce N, Oller A, et al
Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
J Neurooncol. 2021 Sep 9. pii: 10.1007/s11060-021-03842.
PubMed Abstract available

DICPINIGAITIS AJ, Kazim SF, Schmidt MH, Couldwell WT, et al
Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection.
J Neurooncol. 2021 Sep 8. pii: 10.1007/s11060-021-03841.
PubMed Abstract available

BRAUN SE, Aslanzadeh FJ, Lanoye A, Fountain-Zaragoza S, et al
Working memory training for adult glioma patients: a proof-of-concept study.
J Neurooncol. 2021 Sep 7. pii: 10.1007/s11060-021-03839.
PubMed Abstract available

VAN DER LINDEN SD, Rutten GM, Dirven L, Taphoorn MJB, et al
eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial.
J Neurooncol. 2021 Sep 6. pii: 10.1007/s11060-021-03828.
PubMed Abstract available

PENG G, Su J, Xiao S, Liu Q, et al
LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis.
J Neurooncol. 2021 Sep 3. pii: 10.1007/s11060-021-03836.
PubMed Abstract available

LUO T, Ding K, Ji J, Zhang X, et al
Cytoskeleton-associated protein 4 (CKAP4) promotes malignant progression of human gliomas through inhibition of the Hippo signaling pathway.
J Neurooncol. 2021 Sep 2. pii: 10.1007/s11060-021-03831.
PubMed Abstract available

AHMETI H, Borzikowsky C, Hollander D, Rocken C, et al
Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients.
J Neurooncol. 2021 Sep 1. pii: 10.1007/s11060-021-03832.
PubMed Abstract available

NORMAN S, Ramos A, Giantini Larsen AM, Bander E, et al
Impact of the COVID-19 pandemic on neuro-oncology outcomes.
J Neurooncol. 2021;154:375-381.
PubMed Abstract available

HUNTOON K, Makary MS, Damante M, Giglio P, et al
Intraoperative 3 T MRI is more correlative to residual disease extent than early postoperative MRI.
J Neurooncol. 2021;154:345-351.
PubMed Abstract available

BANDER ED, Yuan M, Reiner AS, Garton ALA, et al
Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes.
J Neurooncol. 2021;154:301-313.
PubMed Abstract available

TANAKA R, Inoue K, Yamada Y, Yoshida M, et al
A case of primary CNS embryonal rhabdomyosarcoma with PAX3-NCOA2 fusion and systematic meta-review.
J Neurooncol. 2021;154:247-256.
PubMed Abstract available

SANDHU MRS, Chiang VL, Tran T, Yu JB, et al
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
J Neurooncol. 2021;154:197-203.
PubMed Abstract available

KIM N, Lim DH, Yoon SE, Kim SJ, et al
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy.
J Neurooncol. 2021;154:207-217.
PubMed Abstract available

OTANI R, Mukasa A, Uzuka T, Higuchi F, et al
Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosis.
J Neurooncol. 2021;154:221-228.
PubMed Abstract available

August 2021

PERAGALLO JH, Bruce BB, Vasseneix C, Jariyakosol S, et al
Vision-related quality-of-life in pediatric primary brain tumor patients.
J Neurooncol. 2021 Aug 30. pii: 10.1007/s11060-021-03835.
PubMed Abstract available

NOFFSINGER B, Witter A, Sheybani N, Xiao A, et al
Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner.
J Neurooncol. 2021 Aug 25. pii: 10.1007/s11060-021-03822.
PubMed Abstract available

SEARS TK, Horbinski CM, Woolard KD
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat.
J Neurooncol. 2021 Aug 23. pii: 10.1007/s11060-021-03829.
PubMed Abstract available

APRA C, Guillemot D, Frouin E, Bouvier C, et al
Molecular description of meningeal solitary fibrous tumors/hemangiopericytomas compared to meningiomas: two completely separate entities.
J Neurooncol. 2021 Aug 20. pii: 10.1007/s11060-021-03830.
PubMed Abstract available

XIAO B, Lv SG, Wu MJ, Shen XL, et al
Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis.
J Neurooncol. 2021 Aug 6. pii: 10.1007/s11060-021-03814.
PubMed Abstract available

JIN L, Youngblood MW, Gupte TP, Vetsa S, et al
Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.
J Neurooncol. 2021 Aug 4. pii: 10.1007/s11060-021-03819.
PubMed Abstract available

SCHNEIDER M, Schafer N, Apallas S, Potthoff AL, et al
Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma.
J Neurooncol. 2021 Aug 4. pii: 10.1007/s11060-021-03817.
PubMed Abstract available

TAKAMI H, Graffeo CS, Perry A, Ohno M, et al
Histopathology and prognosis of germ cell tumors metastatic to brain: cohort study.
J Neurooncol. 2021;154:121-130.
PubMed Abstract available

GAZZERI R, Telera S, Galarza M, Callovini GM, et al
Surgical treatment of solitary intradural extramedullary spinal cord metastases from solid cancers of non-neurogenic origin. A multicenter study.
J Neurooncol. 2021;154:101-112.
PubMed Abstract available

DHAWAN S, Venteicher AS, Butler WE, Carter BS, et al
Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.
J Neurooncol. 2021;154:1-11.
PubMed Abstract available

ALEKSONIS HA, Krishnamurthy LC, King TZ
White matter hyperintensity volumes are related to processing speed in long-term survivors of childhood cerebellar tumors.
J Neurooncol. 2021;154:63-72.
PubMed Abstract available

SAITO M, Wages NA, Schiff D
Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma.
J Neurooncol. 2021;154:41-47.
PubMed Abstract available

July 2021

TAKIGAWA K, Hata N, Michiwaki Y, Hiwatashi A, et al
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma.
J Neurooncol. 2021 Jul 28. pii: 10.1007/s11060-021-03812.
PubMed Abstract available

LIN MR, Chen PY, Wang HC, Lin PC, et al
Prevalence of sleep disturbances and their effects on quality of life in adults with untreated pituitary tumor and meningioma.
J Neurooncol. 2021 Jul 24. pii: 10.1007/s11060-021-03811.
PubMed Abstract available

OGINO A, Niranjan A, Kano H, Flickinger JC, et al
Optimizing stereotactic radiosurgery in patients with recurrent or residual craniopharyngiomas.
J Neurooncol. 2021 Jul 20. pii: 10.1007/s11060-021-03806.
PubMed Abstract available

LEE EJ, Choi KS, Park ES, Cho YH, et al
Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review.
J Neurooncol. 2021 Jul 15. pii: 10.1007/s11060-021-03805.
PubMed Abstract available

BUNEVICIUS A, Pikis S, Padilla F, Prada F, et al
Sonodynamic therapy for gliomas.
J Neurooncol. 2021 Jul 12. pii: 10.1007/s11060-021-03807.
PubMed Abstract available

PALMISCIANO P, Haider AS, Nwagwu CD, Wahood W, et al
Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.
J Neurooncol. 2021 Jul 3. pii: 10.1007/s11060-021-03802.
PubMed Abstract available

LIU IC, Holtzman AL, Rotondo RL, Indelicato DJ, et al
Correction to: Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
J Neurooncol. 2021 Jul 1. pii: 10.1007/s11060-021-03798.
PubMed

VAN OPIJNEN MP, van der Meer PB, Dirven L, Fiocco M, et al
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
J Neurooncol. 2021 Jul 1. pii: 10.1007/s11060-021-03800.
PubMed Abstract available

MEHTA GU, Barone AK, Bradford D, Larkins E, et al
US Food and Drug Administration regulatory updates in neuro-oncology.
J Neurooncol. 2021;153:375-381.
PubMed Abstract available

BUSH NAO, Young JS, Zhang Y, Dalle Ore CL, et al
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
J Neurooncol. 2021;153:447-454.
PubMed Abstract available

JOHNSON RA, Do TH, Palzer EF, Cramer SW, et al
Pattern of technology diffusion in the adoption of stereotactic laser interstitial thermal therapy (LITT) in neuro-oncology.
J Neurooncol. 2021;153:417-424.
PubMed Abstract available

June 2021

AHN SS, An C, Park YW, Han K, et al
Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma.
J Neurooncol. 2021 Jun 30. pii: 10.1007/s11060-021-03801.
PubMed Abstract available

MAREIKE M, Franziska SB, Julia E, Daniel H, et al
Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
J Neurooncol. 2021 Jun 29. pii: 10.1007/s11060-021-03794.
PubMed Abstract available

VAN RUITENBEEK NJ, Ho VKY, Westgeest HM, Beerepoot LV, et al
Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery.
J Neurooncol. 2021 Jun 25. pii: 10.1007/s11060-021-03793.
PubMed Abstract available

PORPER K, Shpatz Y, Plotkin L, Pechthold RG, et al
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma.
J Neurooncol. 2021 Jun 21. pii: 10.1007/s11060-021-03786.
PubMed Abstract available

CHO A, Untersteiner H, Fitschek F, Khalaveh F, et al
The clinical relevance of laboratory prognostic scores for patients with radiosurgically treated brain metastases of non-pulmonary primary tumor.
J Neurooncol. 2021 Jun 20. pii: 10.1007/s11060-021-03788.
PubMed Abstract available

BETTAG C, Hussein A, Sachkova A, Bock HC, et al
Implantation of Carmustine wafers after resection of malignant glioma with and without opening of the ventricular system.
J Neurooncol. 2021 Jun 20. pii: 10.1007/s11060-021-03792.
PubMed Abstract available

NEWMAN WC, Goldberg J, Guadix SW, Brown S, et al
The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes.
J Neurooncol. 2021 Jun 19. pii: 10.1007/s11060-021-03790.
PubMed Abstract available

ROSSO DA, Rosato M, Iturrizaga J, Gonzalez N, et al
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated gammadelta T lymphocytes.
J Neurooncol. 2021 Jun 14. pii: 10.1007/s11060-021-03787.
PubMed Abstract available

LIU IH, Holtzman AL, Rotondo RL, Indelicato DJ, et al
Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
J Neurooncol. 2021 Jun 8. pii: 10.1007/s11060-021-03783.
PubMed Abstract available

CASTRO M, Pampana A, Alam A, Parashar R, et al
Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.
J Neurooncol. 2021 Jun 8. pii: 10.1007/s11060-021-03780.
PubMed Abstract available

CHEN YL, Huang AP, Wang CC, Chen HY, et al
Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasis.
J Neurooncol. 2021 Jun 7. pii: 10.1007/s11060-021-03782.
PubMed Abstract available

ADELON J, Dufour C, Foulon S, Masliah Planchon J, et al
What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?
J Neurooncol. 2021 Jun 2. pii: 10.1007/s11060-021-03777.
PubMed Abstract available

LEE MH, Hur KY, Hong SD, Seol HJ, et al
Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.
J Neurooncol. 2021;153:343-350.
PubMed Abstract available

RODRIGUES A, Bhambhvani H, Medress ZA, Malhotra S, et al
Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas.
J Neurooncol. 2021;153:321-330.
PubMed Abstract available

SHEEHAN D, Sheehan K, Sheehan J
Sonodynamic therapy for metastatic melanoma to the brain.
J Neurooncol. 2021;153:373-374.
PubMed

WELLER J, Katzendobler S, Karschnia P, Lietke S, et al
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression.
J Neurooncol. 2021;153:283-291.
PubMed Abstract available

May 2021

EICHBERG DG, Slepak TI, Pascoini AL, Komotar RJ, et al
Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells.
J Neurooncol. 2021 May 24. pii: 10.1007/s11060-021-03778.
PubMed Abstract available

DIJKSTRA BM, de Jong M, Stroet MCM, Andreae F, et al
Correction to: Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
J Neurooncol. 2021 May 20. pii: 10.1007/s11060-021-03769.
PubMed

MOTOMURA K, Chalise L, Ohka F, Aoki K, et al
Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.
J Neurooncol. 2021 May 19. pii: 10.1007/s11060-021-03776.
PubMed Abstract available

OYA S, Ikawa F, Ichihara N, Wanibuchi M, et al
Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan.
J Neurooncol. 2021 May 17. pii: 10.1007/s11060-021-03775.
PubMed Abstract available

ZHONG J, Huang V, Gurbani SS, Ramesh K, et al
3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.
J Neurooncol. 2021 May 13. pii: 10.1007/s11060-021-03770.
PubMed Abstract available

FATIMA N, Shin JH, Curry WT, Chang SD, et al
Microsurgical resection of foramen magnum meningioma: multi-institutional retrospective case series and proposed surgical risk scoring system.
J Neurooncol. 2021 May 10. pii: 10.1007/s11060-021-03773.
PubMed Abstract available

KRAUSS WE, Yolcu YU, Alvi MA, Moinuddin FM, et al
Clinical characteristics and management differences for grade II and III spinal meningiomas.
J Neurooncol. 2021 May 10. pii: 10.1007/s11060-021-03771.
PubMed Abstract available

CROTTY EE, Smith SMC, Brasel K, Pakiam F, et al
Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
J Neurooncol. 2021 May 8. pii: 10.1007/s11060-021-03767.
PubMed Abstract available

EL-KHOULY FE, Veldhuijzen van Zanten SEM, Jansen MHA, Bakker DP, et al
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
J Neurooncol. 2021 May 7. pii: 10.1007/s11060-021-03763.
PubMed Abstract available

CORONA AM, Di L, Shah AH, Crespo R, et al
Current experimental therapies for atypical and malignant meningiomas.
J Neurooncol. 2021 May 5. pii: 10.1007/s11060-021-03759.
PubMed Abstract available

RUTTENS D, Messiaen J, Ferster A, Piette C, et al
Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience.
J Neurooncol. 2021 May 3. pii: 10.1007/s11060-021-03766.
PubMed Abstract available

SANDLER CX, Matsuyama M, Jones TL, Bashford J, et al
Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review.
J Neurooncol. 2021;153:1-14.
PubMed Abstract available

BENDER K, Perez E, Chirica M, Onken J, et al
High-grade astrocytoma with piloid features (HGAP): the Charite experience with a new central nervous system tumor entity.
J Neurooncol. 2021;153:109-120.
PubMed Abstract available

ELTOBGY M, Huntoon K, Musgrave N, Shaikhouni A, et al
Impact of cerebrospinal fluid flow study in patients undergoing intrathecal chemotherapy via ventricular catheter reservoir.
J Neurooncol. 2021;153:161-167.
PubMed Abstract available

RAUCH M, Tausch D, Stera S, Blanck O, et al
MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics.
J Neurooncol. 2021;153:79-87.
PubMed Abstract available

NIEBLAS-BEDOLLA E, Christophers B, Williams JR, Power-Hays A, et al
Racial and ethnic disparities among children with primary central nervous system tumors in the US.
J Neurooncol. 2021;152:451-466.
PubMed Abstract available

LEE CY, Soliman H, Bragagnolo ND, Sahgal A, et al
Predicting response to radiotherapy of intracranial metastases with hyperpolarized [Formula: see text]C MRI.
J Neurooncol. 2021;152:551-557.
PubMed Abstract available

MONTERO AS, Tran S, Amelot A, Berriat F, et al
Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients.
J Neurooncol. 2021;152:491-499.
PubMed Abstract available

April 2021

DASGUPTA A, Geraghty B, Maralani PJ, Malik N, et al
Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema.
J Neurooncol. 2021 Apr 27. pii: 10.1007/s11060-021-03762.
PubMed Abstract available

AVADIAPPAN S, Morrison MA, Jakary A, Felton E, et al
Relationship between 7T MR-angiography features of vascular injury and cognitive decline in young brain tumor patients treated with radiation therapy.
J Neurooncol. 2021 Apr 24. pii: 10.1007/s11060-021-03753.
PubMed Abstract available

SONG J, Aljabab S, Abduljabbar L, Tseng YD, et al
Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy.
J Neurooncol. 2021 Apr 22. pii: 10.1007/s11060-021-03758.
PubMed Abstract available

GILLESPIE CS, Islim AI, Taweel BA, Millward CP, et al
The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.
J Neurooncol. 2021 Apr 22. pii: 10.1007/s11060-021-03761.
PubMed Abstract available

DONO A, Mitra S, Shah M, Takayasu T, et al
PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
J Neurooncol. 2021 Apr 21. pii: 10.1007/s11060-021-03755.
PubMed Abstract available

CHO YA, Kim D, Lee B, Shim JH, et al
Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.
J Neurooncol. 2021 Apr 17. pii: 10.1007/s11060-021-03710.
PubMed Abstract available

O'KEEFFE D, Bambury RM, O'Reilly S
High grade glioma and caregiver burden.
J Neurooncol. 2021 Apr 15. pii: 10.1007/s11060-021-03754.
PubMed

SCHEURING UJ, Ritter S, Martin D, Schackert G, et al
GliPR1 knockdown by RNA interference exerts anti-glioma effects in vitro and in vivo.
J Neurooncol. 2021 Apr 15. pii: 10.1007/s11060-021-03737.
PubMed Abstract available

RUSTE V, Sunyach MP, Tanguy R, Jouanneau E, et al
Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening.
J Neurooncol. 2021 Apr 10. pii: 10.1007/s11060-021-03751.
PubMed Abstract available

VAN DER MEER PB, Koekkoek JAF, van den Bent MJ, Dirven L, et al
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.
J Neurooncol. 2021 Apr 6. pii: 10.1007/s11060-021-03747.
PubMed Abstract available

RUTENBERG MS, Rotondo RL, Rao D, Holtzman AL, et al
Correction to: Clinical outcomes following proton therapy for adult craniopharyngioma: a singleinstitution cohort study.
J Neurooncol. 2021;152:415.
PubMed

BARONI LV, Oller A, Freytes CS, Sampor CV, et al
Intracranial germ cells tumour: a single institution experience in Argentina.
J Neurooncol. 2021;152:363-372.
PubMed Abstract available

ZHANG L, Chen W, Ding C, Hu Y, et al
Gamma Knife radiosurgery as the initial treatment for elderly patients with nonfunctioning pituitary adenomas.
J Neurooncol. 2021;152:257-264.
PubMed Abstract available

CHIBA K, Aihara Y, Kawamata T
Precise detection of the germinomatous component of intracranial germ cell tumors of the basal ganglia and thalamus using placental alkaline phosphatase in cerebrospinal fluid.
J Neurooncol. 2021;152:405-413.
PubMed Abstract available

VAN DER MEULEN M, Dirven L, Bakunina K, van den Bent MJ, et al
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
J Neurooncol. 2021;152:357-362.
PubMed Abstract available

TORDJMAN M, Madelin G, Gupta PK, Cordova C, et al
Functional connectivity of the default mode, dorsal attention and fronto-parietal executive control networks in glial tumor patients.
J Neurooncol. 2021;152:347-355.
PubMed Abstract available

ASHER AL, Alvi MA, Bydon M, Pouratian N, et al
Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.
J Neurooncol. 2021;152:299-311.
PubMed Abstract available

March 2021

BRENNAN PM, Borchert R, Coulter C, Critchley GR, et al
Second surgery for progressive glioblastoma: a multi-centre questionnaire and cohort-based review of clinical decision-making and patient outcomes in current practice.
J Neurooncol. 2021 Mar 31. pii: 10.1007/s11060-021-03748.
PubMed Abstract available

LE VAN T, Graillon T, Jacob J, Vauleon E, et al
Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort.
J Neurooncol. 2021 Mar 28. pii: 10.1007/s11060-021-03741.
PubMed Abstract available

MARTINEZ-PEREZ R, Florez-Perdomo W, Freeman L, Ung TH, et al
Long-term disease control and treatment outcomes of stereotactic radiosurgery in cavernous sinus meningiomas.
J Neurooncol. 2021 Mar 27. pii: 10.1007/s11060-021-03732.
PubMed Abstract available

DIJKSTRA BM, de Jong M, Stroet MCM, Andreae F, et al
Evaluation of Ac-Lys(0)(IRDye800CW)Tyr(3)-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma.
J Neurooncol. 2021 Mar 26. pii: 10.1007/s11060-021-03739.
PubMed Abstract available

ARUN S, Ravisankar S, Vanisree AJ
Correction to: Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
J Neurooncol. 2021 Mar 24. pii: 10.1007/s11060-021-03743.
PubMed

OSTROM QT, Krebs HL, Patil N, Cioffi G, et al
Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US.
J Neurooncol. 2021 Mar 23. pii: 10.1007/s11060-021-03736.
PubMed Abstract available

RITTERBUSCH R, Halasz LM, Graber JJ
Distinct imaging patterns of pseudoprogression in glioma patients following proton versus photon radiation therapy.
J Neurooncol. 2021 Mar 22. pii: 10.1007/s11060-021-03734.
PubMed Abstract available

TABOR JK, Bonda D, LeMonda BC, D'Amico RS, et al
Neuropsychological outcomes following supratotal resection for high-grade glioma: a review.
J Neurooncol. 2021 Mar 21. pii: 10.1007/s11060-021-03731.
PubMed Abstract available

VERMANDEL M, Dupont C, Lecomte F, Leroy HA, et al
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.
J Neurooncol. 2021 Mar 20. pii: 10.1007/s11060-021-03718.
PubMed Abstract available

FULBERT C, Chabardes S, Ratel D
Adjuvant therapeutic potential of moderate hypothermia for glioblastoma.
J Neurooncol. 2021 Mar 19. pii: 10.1007/s11060-021-03704.
PubMed Abstract available

MILLS MN, Thawani C, Figura NB, Oliver DE, et al
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases.
J Neurooncol. 2021 Mar 19. pii: 10.1007/s11060-021-03735.
PubMed Abstract available

SHIRVALILOU S, Khoei S, Esfahani AJ, Kamali M, et al
Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review.
J Neurooncol. 2021 Mar 13. pii: 10.1007/s11060-021-03729.
PubMed Abstract available

MALLA RR, Gopinath S, Gondi CS, Alapati K, et al
Retraction Note to: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
J Neurooncol. 2021 Mar 12. pii: 10.1007/s11060-021-03722.
PubMed

TATEKAWA H, Uetani H, Hagiwara A, Yao J, et al
Preferential tumor localization in relation to (18)F-FDOPA uptake for lower-grade gliomas.
J Neurooncol. 2021 Mar 11. pii: 10.1007/s11060-021-03730.
PubMed Abstract available

NAUNG H, Cohen KJ
An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity.
J Neurooncol. 2021 Mar 10. pii: 10.1007/s11060-021-03727.
PubMed Abstract available

AHN J, Bunevicius A, Sheehan J
Spontaneous pneumocephalus associated with a melanoma brain metastasis: a Case Report.
J Neurooncol. 2021 Mar 9. pii: 10.1007/s11060-021-03728.
PubMed

BURTH S, Ohmann M, Kronsteiner D, Kieser M, et al
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?
J Neurooncol. 2021 Mar 5. pii: 10.1007/s11060-021-03716.
PubMed Abstract available

PATEL SH, Batchala PP, Muttikkal TJE, Ferrante SS, et al
Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.
J Neurooncol. 2021 Mar 4. pii: 10.1007/s11060-021-03720.
PubMed Abstract available

KURDI M, Butt NS, Baeesa S, Alghamdi B, et al
Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies.
J Neurooncol. 2021 Mar 4. pii: 10.1007/s11060-021-03723.
PubMed Abstract available

MAIR MJ, Kiesel B, Feldmann K, Widhalm G, et al
LAG-3 expression in the inflammatory microenvironment of glioma.
J Neurooncol. 2021 Mar 2. pii: 10.1007/s11060-021-03721.
PubMed Abstract available

LIM-FAT MJ, Song KW, Iorgulescu JB, Andersen BM, et al
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
J Neurooncol. 2021 Mar 1. pii: 10.1007/s11060-021-03719.
PubMed Abstract available

DEWIRE M, Erker C, Hummel TR, Chow LML, et al
Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers.
J Neurooncol. 2021;152:107-114.
PubMed Abstract available

AMER N, Taha H, Hesham D, Al-Shehaby N, et al
Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors.
J Neurooncol. 2021;152:67-78.
PubMed Abstract available

February 2021

UNTERBERGER A, Nguyen T, Duong C, Kondajji A, et al
Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
J Neurooncol. 2021 Feb 26. pii: 10.1007/s11060-020-03674.
PubMed Abstract available

KRAFT J, Mayinger M, Willmann J, Brown M, et al
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology.
J Neurooncol. 2021 Feb 23. pii: 10.1007/s11060-021-03714.
PubMed Abstract available

MOMIN AA, Shao J, Soni P, Almeida JP, et al
Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study.
J Neurooncol. 2021 Feb 15. pii: 10.1007/s11060-021-03711.
PubMed Abstract available

HOLUB K, Louvel G
Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy?
J Neurooncol. 2021 Feb 15. pii: 10.1007/s11060-021-03712.
PubMed Abstract available

CIFARELLI CP, Jacques A, Bobko A
Heterogeneity of radiation response in mesenchymal subtype glioblastoma: molecular profiling and reactive oxygen species generation.
J Neurooncol. 2021 Feb 10. pii: 10.1007/s11060-021-03707.
PubMed Abstract available

BORGER V, Hamed M, Ilic I, Potthoff AL, et al
Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection.
J Neurooncol. 2021 Feb 7. pii: 10.1007/s11060-021-03705.
PubMed Abstract available

PRZYBYLOWSKI CJ, Hervey-Jumper SL, Sanai N
Surgical strategy for insular glioma.
J Neurooncol. 2021;151:491-497.
PubMed Abstract available

ROGERS CM, Jones PS, Weinberg JS
Intraoperative MRI for Brain Tumors.
J Neurooncol. 2021;151:479-490.
PubMed Abstract available

KARIMI S, Mansouri S, Nassiri F, Bunda S, et al
Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status.
J Neurooncol. 2021;151:443-449.
PubMed Abstract available

D'AMICO RS, Aghi MK, Vogelbaum MA, Bruce JN, et al
Convection-enhanced drug delivery for glioblastoma: a review.
J Neurooncol. 2021;151:415-427.
PubMed Abstract available

HOLLON T, Orringer DA
Label-free brain tumor imaging using Raman-based methods.
J Neurooncol. 2021;151:393-402.
PubMed Abstract available

CHAN HY, Choi J, Jackson C, Lim M, et al
Combination immunotherapy strategies for glioblastoma.
J Neurooncol. 2021;151:375-391.
PubMed Abstract available

MARTINEZ-PEREZ R, Requena LC, Carrau RL, Prevedello DM, et al
Modern endoscopic skull base neurosurgery.
J Neurooncol. 2021;151:461-475.
PubMed Abstract available

CHEN C, Lee I, Tatsui C, Elder T, et al
Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review.
J Neurooncol. 2021;151:429-442.
PubMed Abstract available

LAKOMKIN N, Van Gompel JJ, Post KD, Cho SS, et al
Fluorescence guided surgery for pituitary adenomas.
J Neurooncol. 2021;151:403-413.
PubMed Abstract available

VOGELBAUM MA, Parney IF, Elder JB, Cahill D, et al
Neurosurgical involvement in clinical trials for CNS tumors.
J Neurooncol. 2021;151:367-373.
PubMed Abstract available

BANDER ED, Sherman JH, Bettegowda C, Aghi MK, et al
Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons.
J Neurooncol. 2021;151:361-366.
PubMed Abstract available

REDJAL N, Venteicher AS, Dang D, Sloan A, et al
Guidelines in the management of CNS tumors.
J Neurooncol. 2021;151:345-359.
PubMed Abstract available

GERMANO IM, Heth J, Jones PS, Aghi MK, et al
Introduction to special issue dedicated to the 35th anniversary of the joint section on tumors.
J Neurooncol. 2021;151:341-343.
PubMed Abstract available

January 2021

VAIDYA KS, Mitten MJ, Zelaya-Lazo AL, Oleksijew A, et al
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.
J Neurooncol. 2021 Jan 30. pii: 10.1007/s11060-021-03703.
PubMed Abstract available

MEDIKONDA R, Srivastava S, Kim T, Xia Y, et al
Development of new brain metastases in triple negative breast cancer.
J Neurooncol. 2021 Jan 29. pii: 10.1007/s11060-021-03702.
PubMed Abstract available

KOMMERS I, Ackermans L, Ardon H, van den Brink WA, et al
Between-hospital variation in rates of complications and decline of patient performance after glioblastoma surgery in the dutch Quality Registry Neuro Surgery.
J Neurooncol. 2021 Jan 28. pii: 10.1007/s11060-021-03697.
PubMed Abstract available

SAUNDERS JT, Holmes B, Benavides-Serrato A, Kumar S, et al
Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
J Neurooncol. 2021 Jan 28. pii: 10.1007/s11060-021-03699.
PubMed Abstract available

KEBIR S, Rauschenbach L, Weber M, Lazaridis L, et al
Machine learning-based differentiation between multiple sclerosis and glioma WHO II degrees -IV degrees using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
J Neurooncol. 2021 Jan 27. pii: 10.1007/s11060-021-03701.
PubMed Abstract available

DONO A, Amsbaugh M, Martir M, Smilie RH, et al
Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.
J Neurooncol. 2021 Jan 25. pii: 10.1007/s11060-020-03689.
PubMed Abstract available

BU L, Hameed NUF, Luo C, Hong P, et al
Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.
J Neurooncol. 2021 Jan 24. pii: 10.1007/s11060-020-03676.
PubMed Abstract available

SHARMA A, Fruth B, Barrera C, Farfour HN, et al
How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians.
J Neurooncol. 2021 Jan 23. pii: 10.1007/s11060-021-03700.
PubMed Abstract available

PATRIZZ A, Dono A, Zhu P, Tandon N, et al
Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
J Neurooncol. 2021 Jan 22. pii: 10.1007/s11060-020-03690.
PubMed Abstract available

HAEREN RHL, Rautalin I, Schwartz C, Korja M, et al
Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology.
J Neurooncol. 2021 Jan 21. pii: 10.1007/s11060-020-03693.
PubMed Abstract available

MALAIZE H, Samoyeau T, Zanello M, Roux A, et al
Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.
J Neurooncol. 2021 Jan 15. pii: 10.1007/s11060-021-03696.
PubMed Abstract available

WEGNER RE, Abel S, D'Amico RS, Mehta GU, et al
Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome.
J Neurooncol. 2021 Jan 11. pii: 10.1007/s11060-020-03663.
PubMed Abstract available

NOWAK-CHOI K, Palmer JD, Casey J, Chitale A, et al
Resected WHO grade I meningioma and predictors of local control.
J Neurooncol. 2021 Jan 9. pii: 10.1007/s11060-020-03688.
PubMed Abstract available

FUJIOKA Y, Hata N, Akagi Y, Kuga D, et al
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
J Neurooncol. 2021 Jan 8. pii: 10.1007/s11060-020-03682.
PubMed Abstract available

ZHANG M, Rodrigues AJ, Pollom EL, Gibbs IC, et al
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
J Neurooncol. 2021 Jan 7. pii: 10.1007/s11060-020-03686.
PubMed Abstract available

GOMES I, Moreno DA, Dos Reis MB, da Silva LS, et al
Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide.
J Neurooncol. 2021 Jan 5. pii: 10.1007/s11060-020-03675.
PubMed Abstract available

SHI W, Blumenthal DT, Bush NAO, Kebir S, et al
Correction to: Global postmarketing safety surveillance of Tumor Treating Fields (TTFields) in patients with highgrade glioma in clinical practice.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03681.
PubMed

OLIVA MA, Staffieri S, Castaldo S, Giangaspero F, et al
Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03673.
PubMed Abstract available

BRAHMBHATT N, Stupp R, Bushara O, Bachman E, et al
Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03664.
PubMed Abstract available

WUMMER B, Woodworth D, Flores C
Brain stem gliomas and current landscape.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03655.
PubMed Abstract available

HABIB A, Pease M, Kodavali CV, Amankulor N, et al
A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03671.
PubMed Abstract available

CHAMPEAUX-DEPOND C, Weller J, Froelich S, Sartor A, et al
Cyproterone acetate and meningioma: a nationwide-wide population based study.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03672.
PubMed Abstract available

CLAVREUL A, Aubin G, Delion M, Lemee JM, et al
What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03666.
PubMed Abstract available

VANMARCKE D, Menten J, Defraene G, Van Calenbergh F, et al
Stroke rate after external fractionated radiotherapy for benign meningioma.
J Neurooncol. 2021 Jan 4. pii: 10.1007/s11060-020-03678.
PubMed Abstract available

SAMARUT E, Lugat A, Amelot A, Scharbarg E, et al
Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.
J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03683.
PubMed Abstract available

NIMBALKAR VP, Kruthika BS, Sravya P, Rao S, et al
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03685.
PubMed Abstract available

BUNK EC, Wagner A, Stummer W, Senner V, et al
5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas.
J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03680.
PubMed Abstract available

HADDAD AF, Young JS, Mummaneni NV, Kasahara N, et al
Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies.
J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03684.
PubMed Abstract available

LEE D, Riestenberg RA, Haskell-Mendoza A, Bloch O, et al
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.
J Neurooncol. 2021 Jan 3. pii: 10.1007/s11060-020-03677.
PubMed Abstract available

LO YT, Ang YLS, Yang VS, Kanavathy DT, et al
Motor deficits at presentation and predictors of overall survival in central nervous system lymphomas.
J Neurooncol. 2021;151:295-306.
PubMed Abstract available

SONI P, Shao J, Momin A, Lopez D, et al
Clear cell histology portends a worse prognosis than other WHO grade II histologies.
J Neurooncol. 2021;151:307-312.
PubMed Abstract available

BONM AV, Gibson AW, Holmberg LA, Mielcarek M, et al
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma.
J Neurooncol. 2021;151:193-200.
PubMed Abstract available

SAMUEL N, Trifiletti DM, Quinones-Hinojosa A, Lunsford LD, et al
Stereotactic radiosurgery training patterns across neurosurgical programs: a multi-national survey.
J Neurooncol. 2021;151:325-330.
PubMed Abstract available

SAVOOR R, Sita TL, Dahdaleh NS, Helenowski I, et al
Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases.
J Neurooncol. 2021;151:241-247.
PubMed Abstract available

SARID N, Bokstein F, Blumenthal DT, Weiss-Meilik A, et al
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
J Neurooncol. 2021;151:211-220.
PubMed Abstract available

BUTENSCHOEN VM, Hubertus V, Janssen IK, Onken J, et al
Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.
J Neurooncol. 2021;151:181-191.
PubMed Abstract available

BECCARIA K, Sabbagh A, de Groot J, Canney M, et al
Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
J Neurooncol. 2021;151:65-73.
PubMed Abstract available

November 2020

FAN KY, Lalani N, LeVasseur N, Krauze A, et al
Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy.
J Neurooncol. 2020 Nov 18. pii: 10.1007/s11060-020-03657.
PubMed Abstract available

POETSCH L, Bronnimann C, Loiseau H, Frenel JS, et al
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
J Neurooncol. 2020 Nov 17. pii: 10.1007/s11060-020-03662.
PubMed Abstract available

SONI P, Davison MA, Shao J, Momin A, et al
Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
J Neurooncol. 2020 Nov 17. pii: 10.1007/s11060-020-03632.
PubMed Abstract available

CHAN RW, Chen H, Myrehaug S, Atenafu EG, et al
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.
J Neurooncol. 2020 Nov 16. pii: 10.1007/s11060-020-03661.
PubMed Abstract available

CHO A, Untersteiner H, Hirschmann D, Fitschek F, et al
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients.
J Neurooncol. 2020 Nov 11. pii: 10.1007/s11060-020-03660.
PubMed Abstract available

NAKADA M, Nakajima R, Okita H, Nakade Y, et al
Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory.
J Neurooncol. 2020 Nov 2. pii: 10.1007/s11060-020-03656.
PubMed Abstract available

FARRELL C, Shi W, Bodman A, Olson JJ, et al
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
J Neurooncol. 2020;150:269-359.
PubMed Abstract available

ZIU M, Kim BYS, Jiang W, Ryken T, et al
The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
J Neurooncol. 2020;150:215-267.
PubMed Abstract available

REDJAL N, Nahed BV, Dietrich J, Kalkanis SN, et al
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.
J Neurooncol. 2020;150:165-213.
PubMed Abstract available

VELAZQUEZ VEGA JE, Brat DJ, Ryken TC, Olson JJ, et al
The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
J Neurooncol. 2020;150:143-164.
PubMed Abstract available

DOMINO JS, Ormond DR, Germano IM, Sami M, et al
Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
J Neurooncol. 2020;150:121-142.
PubMed Abstract available

LUNDY P, Domino J, Ryken T, Fouke S, et al
The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
J Neurooncol. 2020;150:95-120.
PubMed Abstract available

OLSON JJ, Ryken TC
Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.
J Neurooncol. 2020;150:87-93.
PubMed Abstract available

October 2020

CHANG L, Wang J, Zhou F, Wang D, et al
LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
J Neurooncol. 2020 Oct 30. pii: 10.1007/s11060-020-03624.
PubMed Abstract available

RAHMAN M, Parney I
Journal of Neuro Oncology: immunotherapy for brain tumors.
J Neurooncol. 2020 Oct 20. pii: 10.1007/s11060-020-03589.
PubMed

ZAMANIPOOR NAJAFABADI AH, van der Meer PB, Boele FW, Taphoorn MJB, et al
Determinants and predictors for the long-term disease burden of intracranial meningioma patients.
J Neurooncol. 2020 Oct 19. pii: 10.1007/s11060-020-03650.
PubMed Abstract available

HE W, Liu Z, Teng H, Tang L, et al
Pediatric meningiomas: 10-year experience with 39 patients.
J Neurooncol. 2020 Oct 16. pii: 10.1007/s11060-020-03649.
PubMed Abstract available

MCABEE JH, Degorre-Kerbaul C, Valdez K, Wendler A, et al
Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere cultures.
J Neurooncol. 2020 Oct 15. pii: 10.1007/s11060-020-03643.
PubMed Abstract available

HIPP SJ, Goldman S, Kaushal A, Krauze A, et al
A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
J Neurooncol. 2020 Oct 11. pii: 10.1007/s11060-020-03627.
PubMed Abstract available

DEWIRE M, Fuller C, Hummel TR, Chow LML, et al
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
J Neurooncol. 2020 Oct 9. pii: 10.1007/s11060-020-03641.
PubMed Abstract available

SONG Y, Hu Z, Long H, Peng Y, et al
Correction to: A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
J Neurooncol. 2020 Oct 8. pii: 10.1007/s11060-020-03644.
PubMed Abstract available

SELT F, van Tilburg CM, Bison B, Sievers P, et al
Response to trametinib treatment in progressive pediatric low-grade glioma patients.
J Neurooncol. 2020 Oct 7. pii: 10.1007/s11060-020-03640.
PubMed Abstract available

MOROKOFF A, Jones J, Nguyen H, Ma C, et al
Correction to: Serum microRNA is a biomarker for post-operative monitoring in glioma.
J Neurooncol. 2020 Oct 7. pii: 10.1007/s11060-020-03630.
PubMed Abstract available

DE TOMMASI C, Richardson E, Reale M, Jordan J, et al
Evaluation of a novel application of a mindfulness phone application for patients with brain tumours: a feasibility study.
J Neurooncol. 2020 Oct 6. pii: 10.1007/s11060-020-03638.
PubMed Abstract available

DONO A, Vu J, Anapolsky M, Hines G, et al
Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
J Neurooncol. 2020 Oct 3. pii: 10.1007/s11060-020-03634.
PubMed Abstract available

September 2020

SCHNEIDER M, Ilic I, Potthoff AL, Hamed M, et al
Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates.
J Neurooncol. 2020 Sep 29. pii: 10.1007/s11060-020-03629.
PubMed Abstract available

SCHNEIDER M, Potthoff AL, Scharnbock E, Heimann M, et al
Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival.
J Neurooncol. 2020 Sep 29. pii: 10.1007/s11060-020-03625.
PubMed Abstract available

RAMOS-FRESNEDO A, Domingo RA, Vivas-Buitrago T, Lundy L, et al
Multiple meningiomas: does quantity matter? a population-based survival analysis with underlined age and sex differences.
J Neurooncol. 2020 Sep 28. pii: 10.1007/s11060-020-03620.
PubMed Abstract available

DI PERRI D, Tanguy R, Malet C, Robert A, et al
Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
J Neurooncol. 2020 Sep 26. pii: 10.1007/s11060-020-03628.
PubMed Abstract available

WEISS SA, Zito C, Tran T, Heishima K, et al
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
J Neurooncol. 2020 Sep 24. pii: 10.1007/s11060-020-03619.
PubMed Abstract available

June 2020

SENEVIRATNE DS, Hadley AR, Peterson JL, Malouff TD, et al
Assessment of unintended shifts during frame-based stereotactic radiosurgery using cone beam computed tomography image guidance.
J Neurooncol. 2020;148:273-279.
PubMed Abstract available

LIN YY, Wu HM, Yang HC, Chen CJ, et al
Repeated gamma knife radiosurgery enables longer tumor control in cases of highly-recurrent intracranial ependymoma.
J Neurooncol. 2020;148:363-372.
PubMed Abstract available

BERTAUX M, Houillier C, Edeline V, Habert MO, et al
Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study.
J Neurooncol. 2020;148:343-352.
PubMed Abstract available

May 2020

SULEIMAN M, Bunevicius A, Sheehan J
Stereotactic radiosurgery for management of recurring Choroid Plexus Metastases from Non-Small Cell Lung Carcinoma.
J Neurooncol. 2020;148:207-209.
PubMed

MICHAIEL G, Strother D, Gottardo N, Bartels U, et al
Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature.
J Neurooncol. 2020;147:721-730.
PubMed Abstract available

WEIDMAN DR, Palasamudram S, Zak M, Whitney R, et al
The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
J Neurooncol. 2020;147:731-736.
PubMed Abstract available

YEUNG JT, Vesely MD, Miyagishima DF
In silico analysis of the immunological landscape of pituitary adenomas.
J Neurooncol. 2020;147:595-598.
PubMed Abstract available

KANNO H, Yoshizumi T, Shinonaga M, Kubo A, et al
Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
J Neurooncol. 2020;148:29-38.
PubMed Abstract available

MORSHED RA, Reihl SJ, Molinaro AM, Kakaizada S, et al
The influence of race and socioeconomic status on therapeutic clinical trial screening and enrollment.
J Neurooncol. 2020;148:131-139.
PubMed Abstract available

CHEN TW, Jan IS, Chang DY, Lin CH, et al
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
J Neurooncol. 2020;148:165-172.
PubMed Abstract available

NATHAN NH, Connor M, Sizdahkhani S, Ding L, et al
Increased 30-day readmission rate after craniotomy for tumor resection at safety net hospitals in small metropolitan areas.
J Neurooncol. 2020;148:141-154.
PubMed Abstract available

THOMAS C, Metrock K, Kordes U, Hasselblatt M, et al
Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors.
J Neurooncol. 2020;148:39-45.
PubMed Abstract available

MAIR MJ, Wohrer A, Furtner J, Simonovska A, et al
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.
J Neurooncol. 2020;148:187-198.
PubMed Abstract available

WANG H, Wang R, Hu T, Wang Z, et al
Nonfunctioning pituitary adenomas in pediatric and adolescent patients: a clinical analysis of a series of 14 patients.
J Neurooncol. 2020;148:179-186.
PubMed Abstract available

April 2020

SHIN DW, Kim JH, Kim YH, Cho YH, et al
Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
J Neurooncol. 2020;147:339-349.
PubMed Abstract available

GUO Y, He X, Zhang M, Qu Y, et al
Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
J Neurooncol. 2020;147:327-337.
PubMed Abstract available

WILLEKE VM, Anderson MP, Mahadevan A, Rojas R, et al
Epstein Barr virus associated smooth muscle tumors in the central nervous system: a case report and systematic review of the literature.
J Neurooncol. 2020;147:247-260.
PubMed Abstract available

PATEL MP, Kirkpatrick JP, Johnson MO, Healy P, et al
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.
J Neurooncol. 2020;147:477-483.
PubMed Abstract available

PALMER JD, Bhamidipati D, Shukla G, Epperla N, et al
Outcomes after stereotactic radiosurgery for CNS lymphoma.
J Neurooncol. 2020;147:465-476.
PubMed Abstract available

D'AMICO RS, Khatri D, Reichman N, Patel NV, et al
Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.
J Neurooncol. 2020;147:261-278.
PubMed Abstract available

GUPTA T, Maitre M, Gupta P, Krishnatry R, et al
Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
J Neurooncol. 2020;147:405-415.
PubMed Abstract available

March 2020

AMBADY P, Fu R, Szidonya L, Peereboom DM, et al
Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.
J Neurooncol. 2020;147:171-176.
PubMed Abstract available

BETTE S, Gradtke CV, Cammardella JH, Albertshauser J, et al
Perioperative neurocognitive functions in patients with neuroepithelial intracranial tumors.
J Neurooncol. 2020;147:77-89.
PubMed Abstract available

FERREIRA MSV, Sorensen MD, Pusch S, Beier D, et al
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
J Neurooncol. 2020;147:1-14.
PubMed Abstract available

January 2020

LUTHER EM, McCarthy D, Berry KM, Rajulapati N, et al
Hospital teaching status associated with reduced inpatient mortality and perioperative complications in surgical neuro-oncology.
J Neurooncol. 2020;146:389-396.
PubMed Abstract available

NG S, Fomekong F, Delabar V, Jacquesson T, et al
Current status and treatment modalities in metastases to the pituitary: a systematic review.
J Neurooncol. 2020;146:219-227.
PubMed Abstract available

AHSAN SA, Chendeb K, Briggs RG, Fletcher LR, et al
Beyond eloquence and onto centrality: a new paradigm in planning supratentorial neurosurgery.
J Neurooncol. 2020;146:229-238.
PubMed Abstract available

UMEMURA Y, Wang D, Peck KK, Flynn J, et al
DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy.
J Neurooncol. 2020;146:339-346.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.